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In the current dissertation, closely related studies to quantify the mechanism 
underlying enzyme evolution have been discussed. The HIV-1 protease and !-lactamase 
enzymes were used as model systems for these studies. These are well known enzymes 
that are associated with drug resistance and are associated with the pathogenic diseases, 
and therefore, developing molecular level understanding of drug resistance through these 
enzymes has fundamental as well as practical importance.  
 In chapter 2, the relationship between errors in modeled protein structures and 
associated binding affinity predictions to small molecules is established. The results of 
this study are applicable in addressing a wide range of biological questions including 
enzyme evolutionary mechanisms. The next three chapters discuss different aspects of 
HIV-1 protease evolution. In chapter 3, the role of substrate binding in manipulating the 
catalytic activity of HIV-1 protease during evolution has been examined. The results 
suggest that HIV-1 protease can optimize its catalytic activity by manipulating its 
substrate binding affinity. This part of study also emphasizes the importance of 
considering the in-vivo environment while studying physical-chemical aspects of 
enzymatic evolution. In chapter 4, the role of dynamics as a constraint on the evolution of 
HIV-1 protease has been examined. Low frequency motions (dynamics) of an enzyme 
have been suggested to be critical for its function. It has been further suggested that any 
mutation that disrupts these low frequency motions may have an adverse affect on the 
catalytic function of the enzyme. In this part of study, the role of dynamics as a constraint 
on the evolution of HIV-1 protease has been examined by comparing experimental 
 iii 
activity data for over 90 mutants of HIV-1 protease to correlated motion data obtained 
from molecular dynamics simulations of a Michaelis complex.  The results of this study 
suggest that dynamics do not impose a significant constraint on the evolution of HIV-1 
protease.  In chapter 5, the role of fold stability as a constraint on the evolution of HIV-1 
protease is examined. A significant tradeoff between evolvability and fold stability for 
HIV-1 protease was observed in our study. The results of this study suggest that fold 
stability imposes a significant constraint on the evolution of HIV-1 protease, and in future 
attempts to predict evolutionary outcomes (drug resistant mutations), fold stability should 
also be taken into consideration. In chapter 6, the evolution of cefotaximase activity 
within !-lactamase is described. !-lactamase is a bacterial enzyme that catalytically 
hydrolyzes the !-lactam antibiotic, and therefore inactivates these drugs. Five point 
mutations are, however, required in the gene of this enzyme in order to develop 
cefotaximase activity. In this part of our study, we have studied the effect of four drug 
resistant amino acid mutations [A42G, E104K, G238S, and M182T] on the structural 
properties and cefotaximase activity of !-lactamase. Along with the successful 
identification of evolutionary beneficial mutations, our analyses suggest structural 
rearrangement within active site as a possible mechanism for increasing the activity 
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Enzymes are characterized as specific (recognition of substrates), accurate 
(catalysis of chemical reactions), and proficient (acceleration of chemical reactions) in 
their ability to catalyze the biochemical reactions. Enzymes accelerate the rate of 
biochemical reactions to a timescale necessary for living organisms under physiological 
conditions. Enzymes further act as the regulatory units for biochemical processes by 
controlling the relative abundance of the chemical species in the cell. And therefore, the 
enzymatic reactions have very fundamental roles to play in controlling and performing 
most biological processes[1, 2].  
The specificity, accuracy, and proficiency in the function of an enzyme come at 
the cost of its versatility. During the evolution of an organism, the phenotypic properties 
of its functional components (which include enzymes) change to acquire the ability to 
optimally perform the respective functions relevant to its new environment. The 
variations in genetic sequences encoding enzymes, which result in new functional 
capabilities, is termed as “enzymatic evolution”[3]. Enzymatic evolution under strong 
selection plays a critical role in the development of drug resistance in viruses and 
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bacteria[4-6]. Considering these facts, developing a molecular level understanding of the 
principles governing enzymatic evolution has both fundamental and practical importance. 
Until very recently, the understanding of evolution was limited to the analyses of 
evolutionary outcomes. However, the synthesis of evolutionary biology and experimental 
molecular biology (functional synthesis) have brought a new and exciting era in the study 
of evolution[7]. The empirical fitness landscapes of enzymatic evolution, which were 
constructed using this approach, have provided new insights into enzymatic evolution by 
exploring evolutionary intermediates and pathways[7, 8]. A detailed discussion about the 
functional synthesis approach and its applications can be found in a review by Dean and 
Thornton[7]. Some of the very fundamental questions regarding fitness landscapes of 
enzymatic evolution and accessible evolutionary pathways from suboptimal allele to 
optimal allele for enzymes have been successfully addressed using the functional 
synthesis approach[7, 8]. Growing experimental information about evolutionary 
intermediates and pathways of enzymes has provided a firm basis for molecular level 
analysis of enzymatic evolution.  
The theoretical and computational approaches to study the biological processes 
not only provide a molecular level insight into the process of interest, but also shed light 
on the microscopic origin of its driving force. A very detailed discussion about several 
aspects of computational biology can be found in a special issue edited by Christopher 
Surridge in Nature Insight Nov 2002[9]. Recent advancements in the computational 
modeling, simulation and free energy estimation techniques, in conjunction with 
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transition state theory, have provided new insights into catalytic process of enzymes. The 
proposal for enzyme catalysis has evolved from “...the entire and sole source of catalytic 
power [of enzymes] is the stabilization of the transtion state ..”[10] to “The entire and 
sole source of the catalytic power of enzymes is due to the lowering of the free energy of 
activation and any increase in the generalized transmission coefficient, as compared to 
that of uncatalyzed reaction.”[11]. The computational techniques have also been shown 
to be successful in predicting the effect of amino acid mutations on catalytic efficiency of 
enzymes[12, 13].  
The development of a physical-chemical model which can accurately explain 
enzymatic evolution and can help in predicting the evolutionary outcome of an enzyme 
under strong selection has a great deal of implications. With the aim to help developing 
such model, the research presented in current dissertation focuses on the quantification of 
the mechanism underlying enzymatic evolution, using computational techniques.  
Starting with the chapter 2, we have first assessed the effect of errors in modeled 
protein structures on binding affinity predictions to small molecules. A huge gap exists 
between the number of known sequences and number of known three dimensional 
structures of proteins. This structure-sequence gap brings computational structure 
prediction algorithms into perspective, which provide a relatively quick and economical 
solution to this problem[14]. However, the computational modeling techniques use 
various approximations, which almost always result in some error in the modeled 
structure[15]. As modeled structures are frequently used in the calculation of binding 
4
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affinities to small molecules, information relating the accuracy of these calculations to 
the structural accuracy of the model would be a valuable component in these studies. 
With the help of molecular dynamics simulations and computational free energy 
estimation techniques, the relationship between protein structural error and resulting error 
in binding affinity of small molecule has been established. The results of this study have 
applicability in addressing a broad range of biological questions which involve estimation 
of small molecule binding affinity with modeled structure. 
In next three chapters, different aspects of the evolution of HIV-1 protease have 
been studied. The HIV-1 protease catalyzes the hydrolysis of Gag and Gag-Pol 
polyproteins of new virus at twelve different sites, and therefore has a key role to play in 
viral maturation process[16]. The replication process of HIV-1 virus, however, is less 
efficient and erroneous, which results in the rapid accumulation and selection of different 
mutational variants of HIV-1 protease[5]. This process of accumulating mutants can be 
seen as an evolutionary event. In the chapter 3, we have studied the evolution of catalytic 
function in HIV-1 protease by examining the role of substrate and transition state binding 
in describing the activities of different mutants of HIV-1 protease, within the context of 
its biological environment. In the first step of our study, we have developed a numerical 
model describing the activity of HIV-1 protease in the in-vivo condition, which suggested 
that substrate binding could play a determining role in describing the catalytic activities 
of mutant enzymes.  We have further emphasized the role of substrate binding by 
predicting the relative activities of a statistically significant number of mutants based on 
estimated change in substrate binding, along with change in transition state binding upon 
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these mutations. Further, in the study of 40 different amino acid mutations, no correlation 
was observed between change in substrate and transition state binding. This suggests that 
substrate specificity and catalytic activity in HIV-1 protease can be optimized 
independently during the evolution.  This part of our study also emphasizes the 
importance of considering the in-vivo environment while studying enzymatic evolution.  
In the next part of our study, we have examined the role of dynamics as a 
constraint on the evolution of HIV-1 protease. In a number of experimental and 
theoretical studies, it has been suggested that the collective motions (dynamics) of 
different segments of enzyme play a critical role in accelerating the reaction, and 
disrupting these collective motions may adversely affect the rate of the reaction[17-19]. 
The correlated motions of the residues has been extensively used as the parameter for 
characterizing the protein dynamics and it has been suggested that mutations in 
negatively correlated regions can disrupt the catalytic activity of enzyme[20], and 
therefore can impose a constraint on the evolution of an enzyme. In chapter 4, we have 
examined the role of dynamics as a constraint on the evolution of HIV-1 protease by 
comparing experimental data for over 90 mutants of HIV-1 protease[21], to correlated 
motion data obtained from molecular dynamics simulations of the Michaelis complex. 
The results from numerous analyses do not show any significant relationship between 
correlated motion and enzyme activity for HIV-1 protease. And therefore, our study 




In chapter 5, we have examined the role of fold stability on the evolvability 
(ability of enzyme to acquire mutations) of HIV-1 protease. A change in fold stability of 
an enzyme upon mutations can have a deleterious effect on its functional properties, and 
therefore can impose significant constraints on its evolution[22]. Considering the fact that 
HIV-1 protease is stable by only ~1.05 kcal/mol[23], the change in fold stability could 
play a critical role in describing evolutionary pathways and outcomes of this enzyme. In 
this part of our study, we have first examined the relationship between mutational effect 
on catalytic efficiency and its effect on fold stability of HIV-1 protease. We observed a 
significant correlation between loss in activity and decrease in fold stability. Further, we 
have compared the mutational patterns in Stanford HIV-1 sequence database[24] to the 
change in fold stability caused by relevant mutations, and observed a significant tradeoff 
between evolvability and fold stability for HIV-1 protease. Our study suggests that fold 
stability imposes a significant constraint on the evolution of HIV-1 protease, and in future 
attempts to predict drug resistant mutations, fold stability should also be taken into 
consideration.  
In chapter 6, we shift our focus from HIV-1 protease to -lactamase. -lactamase 
is a bacterial enzyme that causes resistance against -lactam antibiotic by catalytically 
hydrolyzing these drugs[6, 25, 26]. Five point mutations are, however, required in the 
gene of this enzyme in order to be able to efficiently hydrolyze cefotaxime (a third 
generation cephalosporin-based antibiotic)[27, 28]. In an experimental study, it has been 
shown that only selected mutational trajectories to these five point mutations are 
assessable during the enzymatic evolution for resistance against cefotaxime[29]. 
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Therefore, developing a molecular level understanding of the acquisition process of drug 
resistant mutations in -lactamase is not only critical in designing newer generation 
antibiotic drugs, but also provides insight into evolutionary mechanism of enzymes. In 
this part of our study, we have examined the effect of four drug resistant mutations 
[A42G, E104K, G238S, and M182T] on the structural properties and cefotaximase 
activity of -lactamase. We have been able to successfully identify the evolutionary 
beneficial mutations (G238S and E104K) at the first step of evolution. In addition to this, 
we have identified the structural rearrangement within active site as the plausible 
mechanism for increasing the activity against cefotaxime.  This study has not only 
provided a molecular level insight into the effect of four drug resistant mutations on the 
structure and function of -lactamase, but also paved the way for future molecular level 
analysis of a complete mutational trajectory for this class of enzyme.  
In summary, the research presented in current dissertation provides molecular 
level insight into the evolutionary mechanisms of HIV-1 protease and -lactamase. 
Considering the pathological importance of these two enzymes, our research not only 
brings new insight into evolution of enzymes in general, but also has implications in 
developing strategies against the evolution of drug resistance associated with these 





THERMODYNAMIC RESOLUTION: HOW DO ERRORS IN MODELED 
PROTEIN STRUCTURES AFFECT BINDING AFFINITY PREDICTIONS? 
This work has been published as: 
Singh, M.K and Dominy, B.N, Thermodynamic Resolution: How do Errors in Modeled 
Protein Structures Affect Binding Affinity Predictions? Proteins, 2010, 78(7):1613-7 
ABSTRACT 
 
The present study addresses the effect of structural distortion, caused by protein 
modeling errors, on calculated binding affinities toward small molecules. The binding 
affinities to a total of 300 distorted structures based on five different protein-ligand 
complexes were evaluated to establish a broadly applicable relationship between errors in 
protein structure and errors in calculated binding affinities. Relatively accurate protein 
models (less than 2 Å RMSD within the binding site) demonstrate a 14.78 (±7.5)% 
deviation in binding affinity from that calculated by using the corresponding crystal 
structure. For structures of 2-3 Å, 3-4 Å, and >4 Å RMSD within the binding site, the 
error in calculated binding affinity increases to 20.8 (±5.98), 22.79 (±11.3), and 29.43 
(±11.47)%, respectively. The results described here may be used in combination with 
other tools to evaluate the utility of modeled protein structures for drug development or 




The determination of a three-dimensional structure from a novel protein sequence 
is often a necessary step in quantifying molecular recognition and therefore key to 
understanding its biological function. Computational methods that predict three-
dimensional protein structures have been enjoying a growing interest among researchers 
recently, due to the rapidly growing body of sequence data and the time requirements of 
current experimental structure determination methods. Homology modeling approaches 
are widely used to generate high-resolution protein structural models[15, 30]. However, 
de novo techniques and other classes of protein structure prediction algorithms continue 
to show remarkable accomplishments and continuous progress[31]. 
Due to the various approximations used in computational structure prediction 
methods, some error in modeled structures is always expected. Structural accuracy 
assessment, therefore, has been considered an important step in protein modeling. 
Significant efforts have been made to develop algorithms capable of efficiently assessing 
the overall accuracy of modeled structures, and even the accuracy within particular 
regions of interest such as binding sites[32, 33]. These algorithms are predictive and 
provide an estimate of structural error without direct knowledge of the experimentally 
determined structure. 
Modeled protein structures are used in further analyses to address biophysical 
questions. The degree of error that may be tolerated in the protein structure will be 
dependent on the analyses for which these modeled structures are used as input. In 
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addition to straightforward structural analyses, protein models are often used as the basis 
for thermodynamic property calculations. The development of algorithms for predicting 
the structural accuracy of protein models suggests the possibility of further assessing the 
utility of these models for predicting thermodynamic quantities. As modeled protein 
structures are often used in the calculation of binding affinities to small molecules, 
information relating the accuracy of these calculations to the structural accuracy of the 
model would be a valuable component in these investigations. Addressing this problem 
for the end users of protein structural modeling, the present study has been designed to 
systematically quantify the effect of structural distortion of protein models on the 





A summary of the approach taken in this study is as follows. First, a group of five 
structurally distinct protein–ligand complexes were chosen from the protein 
databank[34]. The protein structures were then intentionally distorted to represent 
modeled structures with some intrinsic error. The degree of distortion in the structures 
was then quantified in terms of the root mean squared deviation (RMSD) of the binding 
site residues. The binding free energy calculations were then performed on each of the 
distorted complexes and compared to the binding free energy calculated from 
corresponding crystal complexes. From these results, the error in calculated binding 
affinities is related to the error in the structure. 
1. Generating non-native structures 
The PDB IDs of five protein–ligand complexes chosen for the present study are 
1D7J, 5CYH, 2IFB, 1LKK, and 1FKF[34]. These complexes represent a variety of 
protein classes including reductases, isomerases, fatty-acid binding proteins, and the 
kinase SH2 domain. By investigating these complexes with distinct folds and ligand 
structures (figure 2.1), the results of this study should be more generally applicable and 
independent of the structural details of any particular protein. 
In the process of generating the non-native (perturbed) structures, the crystal 
structures of the protein components of all the five protein–ligand complexes were used. 
The protein structures were initially minimized for 50 steps using a steepest descent (SD) 
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algorithm to remove clashes. The systems were then gradually heated from 100 to 300 K 
over 300 ps with an RMSD restraint on the binding site atoms, in order to perturb the 
structure to a target RMSD value. The target RMSD values ranged from 1 to 6 Å. The 
RMSD restraint was removed after heating, and the simulations were run for a further 2 
ns to allow for equilibration. The implicit solvent GBSW[35] module in CHARMM[36] 
was used to represent the implicit solvent environment while performing all energy 
minimizations and molecular dynamics simulations. In addition, a cutoff of 16 Å was 
used. The final structures of these simulations represent protein models with some 
structural error and were used for calculation of RMSD values (relative to the crystal 
structures), which are plotted on the x-axis of figures 2.2-2.8. 
Although calculated binding affinities are sensitive to specific structural details, 
the RMSD measure used to evaluate structural distortion is less sensitive. In order to 
compensate for the coarse nature of the RMSD measure, multiple structures 
corresponding to each target RMSD value were generated. The above procedure was 
repeated using different combinations of the force constant, target RMSD value in the 
RMSD restraint, and seed values for initial velocity assignments to generate a total of 319 
perturbed structures. The large number of perturbed structures generated is used to 
provide a statistically robust measure of the relationship between structural error and the 
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Figure 2.1: The structures of the ligands used in the present study. (a) 4-hydroxy-2-butanone 
(1D7J.pdb); (b) palmitic acid (2IFB.pdb); (c) GLY-PRO [5CYH.pdb]; (d) ACE-PTR-GLU-GLU-





2. Modeling non-native protein–ligand complexes 
The corresponding ligands were optimally replaced into the binding pocket of 
each perturbed structure by superimposing the binding site atoms on the native protein–
ligand complex structure. Superimposition was performed by rotating and translating the 
entire perturbed structure in order to minimize the binding site atomic RMSD toward the 
native complex. The systems were then minimized for 500 steps using an SD algorithm 
with a harmonic restraint applied to the protein component using a force constant of 10 
kcal/mol/Å2. 
3. Evaluating structural error 
A quantitative measure of structural error is necessary to establish a relationship 
between structural error and the error in a binding affinity calculation. In the present 
study, structural distortion is quantified in terms of the RMSD with respect to the binding 
site residues, defined as the amino acids for which at least one atom is within 4.5 Å of the 
ligand in the reference structure. The binding site residue RMSD measure provides 
information about atoms forming direct atomic interactions with the ligand and therefore 
most relevant to binding. RMSD values for the binding site residues were assessed by 
comparing the perturbed complex structures with the corresponding crystal complex. 




4. Calculating binding affinity using an MM-GBSA approach 
Binding affinities calculated using a single trajectory MM-GBSA technique were 
then determined for all 319 perturbed complexes and compared to the binding energy 
calculated using the corresponding crystal structure. While the accuracy of such endpoint 
methods have been questioned in the determination of absolute binding affinities, these 
methods have been used successfully in evaluating relative binding affinities[37, 38].  In 
addition, the focus of the current study is to evaluate the impact of structural error on 
thermodynamic property calculations, and not to assess the accuracy of the 
thermodynamic calculations themselves. Further, the inherent speed of the MM-GBSA 
approach was necessary to arrive at a statistically meaningful result based on over 300 
perturbed complex structures. 
The binding affinities for the perturbed and crystal complexes were determined 
using the following protocol. The complexes described above were gradually heated from 
200 to 300 K over 200 ps with a weak harmonic restraint of 2 kcal/mol/Å2 applied to all 
atoms of the protein component. The harmonic restraint was gradually removed over 200 
ps of simulation followed by 3.6 ns of equilibration and 2 ns of production. 2000 
snapshots extracted every 1 ps from each production run were used to estimate the 
binding free energy using the MM-GBSA technique[39]. 
A detailed description of the MM-GBSA protocol can be found elsewhere[39-41]. 
In this study, gas phase energies of the each component (complex, protein, and ligand) 
were calculated in CHARMM, using a nonbonded cutoff of 16 Å. The polar solvation 
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energies were calculated using the GBSW module of CHARMM. The nonpolar solvation 
energies were calculated separately using a solvent accessible surface area model with a 
microscopic surface tension proportionality constant of 0.00542 kcal/mol/Å2 and a 
correction factor of 0.92 kcal/mol, as described previously[42]. Entropy estimates were 
calculated with the snapshots extracted every 40 ps from the production run. Vibrational 
entropy terms were calculated by a normal mode approximation using the VIBRAN 
module in CHARMM with a distance dependent dielectric using a coefficient of 4 and 
nonbonded cutoff of 12 Å. Translational and rotational entropy components were also 
estimated within the VIBRAN module of CHARMM. 
For the analysis, the free energies were grouped into blocks corresponding to 
structures of <2 Å, <3 Å, <4 Å, and >4 Å RMSD based on all atoms of the residues in the 
binding site. The percent error in binding affinity was evaluated with respect to that of 
calculated with crystal structure and averaged within these blocks. There were relatively 
few structures of <1 Å RMSD, and therefore these were included in a <2 Å RMSD block. 
Any of the 319 distorted complex structures resulting in an unphysical positive binding 
affinity were excluded from the study, leaving 300 structures available for analysis. 
The MM-GBSA binding affinities of the native complexes, their experimentally 
determined binding affinities, and the MM-GBSA binding affinities of all distorted 




RESULTS AND DISCUSSION 
The results qualitatively suggest, as expected, that the lower the RMSD, the 
higher chance of calculating a free energy of binding close to that calculated using the 
native structure (figure 2.2). As the protein structures become more perturbed (higher 
RMSD), the chance of calculating an accurate binding affinity decreases. For structures 
of <2 Å RMSD from the crystal complex, the chance of correctly calculating the binding 
free energy is usually highest among all the structures (between 10 and 28% error). For 
the structures of >2 Å RMSD, the error in the free energy becomes more sensitive to the 
structure of the protein and ligand (up to 44% error). Depending on how well new 
contacts are compensating for lost native contacts, especially the hydrogen bond and 
ionic pair contacts, the free energy of binding may or may not be close to the native 
binding affinity after high structural distortion. The increasing variance in the calculated 
percent errors of the binding affinities as a function of RMSD is primarily the result of 
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Figure 2.2: Percent error in binding affinity upon structural distortion of all atoms of binding site 
residues for all five systems studied. Zero RMSD corresponds to the native structure. 
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1. Error in binding affinity generalized over all protein–ligand complexes 
Previously, we have described the average percent error in binding affinity as a 
function of structural error (RMSD) for five structurally diverse protein complexes. Now 
we generalize these results by averaging over the individual protein complex results 
(figure 2.3). In general, the error in the calculated binding affinity increases 
monotonically with the error in binding site structure. Further, the standard deviations in 
the binding affinity error generally increase with structural error, resulting from the 
increased structural diversity represented in higher RMSD values, in some cases, 
resulting in interactions that compensate for lost native interactions. For the structures of 
<2 Å RMSD, the average percent error in calculated binding affinity is lowest with the 
value of 14.78 (±7.5). For the structure with RMSD between 2–3 Å, 3–4 Å, and >4 Å, the 
































Figure 2.3: Percent error in binding affinity on structural distortion of binding site averaged over 
the five diverse protein–ligand complexes studied. 
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2. Role of ligand structure 
Some further insight into the results can be gained by shifting the focus from the 
protein structure to the chemical structure of the ligand. The ligands from the 1D7J and 
2IFB complexes, both of which have one hydrogen bond donor and two hydrogen bond 
acceptors, show a relatively steep change in the binding affinity error upon structural 
distortion (figure 2.2). This can be explained by the fact that during the molecular 
dynamics simulation, these ligands can adopt orientations in the restructured binding sites 
that on average lower the binding affinity (figure 2.4). This favorable binding free energy 
is partially due to the result of improved electrostatic interactions between the ligands and 
the corresponding restructured binding sites (figure 2.5). In contrast, the ligands with 
more hydrogen bond donors and acceptors (1LKK, 5CYH, 1FKF) show a weakening of 
the average binding free energy upon restructuring of the binding site (figure 2.4).  
The role of ligand structure in describing the error in calculated binding affinity 
upon structural distortion of binding site can further be examined by observing the 
direction of the change in binding free energy component. In order to get further insight 
into role of ligand structure,  we have calculated net change (G) within each block of 
RMSD for the electrostatic (Coulombic and  solvation) and van der Waals components 
along with total binding free energy,  along with calculating the absolute change in 
binding free energy (|G|). 
For 1D7J and 2IFB, which form relatively few hydrogen bonds or Coulombic 
interactions with its ligand, the relatively steep change in the binding free energy upon 
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structural distortion (figure 2.2) is primarily described by the favorable electrostatic 
component of free energy (figure 2.5). Upon structural distortion of binding site, both 
complexes show significant favorable change in Coulombic interactions with high 
variance within each RMSD block. This demonstrates the possible structural 
rearrangement of the ligands in the restructured binding pocket and thereby resulting in 
more favorable interactions (figure 2.6). The solvation components of the free energy 
show similar trend but in opposite direction along with high variance within each block 
(figure 2.7).  
The ligand of 1LKK, which has several hydrogen bond donors and acceptors 
along with charged groups, shows significant unfavorable change in free energy of 
binding upon structural distortion of the binding site (figure 2.4). This observation can be 
attributed to the loss of the huge network of Coulombic interactions present in the native 
complex that result mostly in the loss of binding affinity (figure 2.5, 2.6).   
The 5CYH also shows a loss in Coulombic interactions upon structural 
distortionof binding site. One difference is that the lost Coulombic interactions seem to 
be significantly compensated by the more favorable solvation free energy. And therefore, 
the total electrostatic component of free energy is relatively insensitive to the structural 
distortion (figure 2.5). A similar phenomenon of compensation of columbic free energy 
with solvation component of free energy can be observed with the 1FKF complex. 
No considerable relationship was observed between ligand structures and change 
in van der Waals components of free energy upon structural distortion (figure 2.8). 
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However, there is significant change in van der Waals component upon structural 
distortion.   The solute entropic term and the solvent accessible surface area terms were 















































































Figure 2.4: Percent change in binding affinity [%G] upon structural distortion of binding site 






































































Figure 2.5: Percent change in electrostatic component of binding affinity [%G(elec)] upon 
structural distortion of binding site compared to the electrostatic component of free energy of 












































































Figure 2.6: Percent change in Coulombic component of binding affinity [%G(Coul)] upon 
structural distortion of binding site compared to the Coulombic component of free energy of 















































































Figure 2.7: Percent change in polar solvation component of binding affinity [%G(GB)] upon 
structural distortion of binding site compared to the polar solvation component of free energy of 




































































Figure 2.8: Percent change in van der Waals component of binding affinity [%G(vdW)] upon 
structural distortion of binding site compared to the van der Waals component of free energy of 





The estimate of error in calculated binding affinities on structural distortion, 
evaluated in this study, could be used while deciding on the utility of a particular 
modeled structure, or as the selection criteria during the modeling process. This study and 
other future studies provide a critical connection between the development of protein 
structural models and their use in predicting and characterizing thermodynamic 
properties. We believe that the results in this study will help researchers in assigning a 
level of confidence for applications of modeled protein structures involving small-









The evolution of species is a complex phenomenon based on the optimization of a 
multidimensional function referred to as the fitness. At the level of biomolecular 
evolution, the fitness function can be reduced to include physiochemical properties 
relevant to a particular molecule’s biological function. In this work, questions involving 
the physical-chemical mechanisms underlying the evolution of HIV-1 protease are 
addressed through molecular simulation and subsequent analysis of thermodynamic 
properties related to the activity of the enzyme. Specifically, the impact of 40 single 
amino acid mutations on the binding affinity toward the MA/CA (Ser-Gln-Asn-Tyr/Pro-
Ile-Val-Gln) substrate and corresponding transition state intermediate has been 
characterized using a Molecular Mechanics Poisson-Boltzmann Surface Area (MM-
PBSA) approach. It is demonstrated that this approach is capable of extracting 
statistically significant information relevant to experimentally determined catalytic 
activities. Further, no correlation is observed between the effect of mutations on substrate 
and transition state binding, suggesting independent evolutionary pathways toward 
optimizing substrate specificity and catalytic activity. In addition, a detailed analysis of 
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calculated binding affinity data suggests that ground-state destabilization (reduced 
binding affinity for the substrate) could be a contributing factor in the evolutionary 
optimization of HIV-1 protease. A numerical model is developed to demonstrate that 
ground-state destabilization is a valid mechanism for activity optimization given the high 




The evolution of organisms can be described as occurring in the context of a fitness 
landscape that maps genetic information onto phenotypic properties and their interaction 
with the environment. One class of phenotypic property is the catalytic efficiency of 
enzymes expressed within the species. Enzymes act to enhance the rate of biochemical 
reactions and consequently are also critical in kinetically controlling the concentrations of 
metabolic products within the organism. The catalytic activity of enzymes is therefore 
inextricably linked to the survival of the organism and the propagation of the species. The 
functional properties of enzymes evolve along with the organism in order to optimize the 
specific metabolic functions of these organisms, thereby aiding in the ability of the 
organism to adapt to its environment. The essential contribution of enzymes to the fitness 
of an organism links the evolution of these molecules to the broader evolution of species. 
In considering the HIV virus, the constituent enzyme HIV-1 protease is known to 
play an essential role in the lifecycle of the pathogen. The enzyme catalyzes the 
hydrolysis of specific peptide bonds releasing constituent proteins from the Gag and Pol 
polyproteins during viral maturation to an infectious form [43]. Inhibition of this enzyme 
is a key treatment strategy for halting the viral lifecycle and preventing the progression of 
disease. Treatment of AIDS using protease inhibitors has further demonstrated that the 
evolution of HIV-1 protease is closely linked to the survival of the HIV virus.  
While the essential role of the protease makes it an attractive target for drug therapy, 
the rapid replication rate (108-109 virions/day) of the virus, complemented by the high 
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error rate of reverse transcriptase (about 1 in 10,000 base pairs), results in the rapid 
accumulation and selection of drug resistant variants of the HIV-1 protease [43]. This 
drug resistance process results in the selection of viral enzymes that avoid strong 
interactions with drugs, but still maintain sufficient catalytic efficiency for the survival of 
the virus. Drug resistance continues to be seen as one of the most challenging problems 
resulting from molecular evolution.  
Considering the important treatment implications of understanding the drug resistance 
process in HIV-1 protease, numerous experimental studies have been performed on the 
structure as well as the activity of different mutants.  The availability of an extensive 
amount of experimental information regarding various mutants makes HIV-1 protease an 
excellent model system for the theoretical characterization of enzymatic evolution. 
Development of a rationale describing the appearance of specific mutations in HIV-1 
protease, with and without drug pressure has implications for improved inhibitor design 
as well as giving fundamental insight into the mechanisms of enzyme evolution.  
 The characterization of physical mechanisms governing the effect of mutations on 
the catalytic efficiency of HIV-1 protease can be considered as a step toward 
understanding the molecular evolutionary process.  From the perspective of molecular 
modeling, this process involves modeling the reaction catalyzed by the enzyme and the 
effect of a mutation on the catalytic process. The modeling of the reaction itself suggests 
the need for quantum mechanical models that properly evaluate the energy changes 
occurring during the bond breaking and forming process. However, modeling large 
molecules over long (ns or longer) time scales typically requires the use of classical 
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potentials. Considering these two competing factors, the QM/MM model has been 
historically applied to the study of enzyme catalysis, successfully addressing the chemical 
mechanisms associated with enzyme catalysis [44]. However, the extensive 
computational time required for these QM/MM calculations constitutes a significant 
challenge for studying a large number of mutations, which is often necessary while 
characterizing broader evolutionary aspects of enzyme catalysis.   
The use of classical molecular mechanics models to assess enzyme catalysis can fill 
an important role in studying the evolution of enzyme function. Such models tend to be 
computationally tractable for studying the effect of a large number of mutations on 
enzyme activity. One of the classical approaches for studying enzyme catalysis involves 
the consideration of a ground state model of the transition state, often described as a 
transition state analogue [45]. These transition state analogue models can be used in the 
context of a classical molecular mechanics protocol to evaluate the effect of mutations on 
transition state binding. The transition state binding effects can then be used to describe 
the effects on enzyme activity through transition state theory [46]. This reduces the 
problem of estimating changes in activity to estimating the changes in binding affinity 
upon mutation, a task suitable to classical molecular mechanics approaches.  By using 
computationally tractable classical models, it is possible to characterize larger portions of 
the evolutionary landscape with the aim of identifying common physical mechanisms 
underlying the process of enzyme evolution. 
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The calculated activities obtained for different mutants in the current study were 
compared to activity data determined using a bacteriophage lambda-based genetic screen 
system that closely captures the in-vivo conditions associated with HIV-1 protease 
function [47-49]. A statistically significant correlation between the calculated and 
experimental activity data for HIV-1 protease was observed. In addition, analyses on 40 
single amino acid mutants of HIV-1 protease indicate that most mutations, as expected, 
destabilize transition state binding resulting in reduced activity. In addition, however, 
most mutations appear also to enhance binding to the ground state, also resulting in 
reduced activity as characterized through max. The enhancement of enzyme catalyzed 
reaction rates through ground state destabilization is consistent with the Michaelis-
Menten mechanism under conditions where the substrate concentration is not 
significantly smaller than KM. A numerical analysis of HIV-1 protease catalysis in the 
immature viral particle environment suggests that the protease is acting and evolving 
under such conditions. Further analyses also demonstrate that the impact of mutations on 
ground state binding is only weakly correlated to the impact on transition state binding. 




THEORETICAL BACKGROUND OF PROTEASE ACTIVITY CALCULATION 
The complete equation describing the peptide hydrolysis reaction catalyzed by the 
HIV1 protease can be written as 
           (3.1)                                                  
The above reaction can also be represented in terms of the free energy change with 
respect to the reaction coordinate as shown in figure 3.1. Assuming that the activation 
energy barrier of the first two steps is sufficiently low and the concentration of the active 
conformer of the enzyme [E]0, which can form a complex with the substrate, is primarily 
governed by the free energy difference between the folded, unfolded and dimer form of 
enzyme, one can focus on steps 3, 4 and 5 of reaction 3.1 for the study of enzyme 
catalysis. For these catalytic steps, the Michaelis-Menten formulation provides a widely 
accepted quantitative description of enzyme catalysis [50, 51]. The rate of the reaction 
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Figure 3.1: Profile of a peptide hydrolysis reaction catalyzed by the HIV-1 protease. 
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A mutation in the HIV-1 protease potentially can have an effect on transition state 
binding, substrate binding and/or the stability of the active conformer of the protein. In 
the first case where a mutation affects transition state binding, the activation energy 
barrier (G‡cat) and consequently kcat will be affected, which will affect the rate of the 
corresponding reaction. In the second case, where a mutation affects substrate binding, 
the effect on catalytic efficiency is highly dependent on the concentration of the substrate. 
If the substrate concentration is low compared to the Michaelis constant (KM), the 
concentration of the enzyme substrate complex will be governed by the reversible step 2 
of reaction 3.1, and the change in substrate binding affinity will affect the forward and 








GSexp ). Therefore, according to equation 3.2, this will have no affect on the 
reaction rate. However, in the case of a high substrate concentration relative to KM, the 
enzyme binding sites will be saturated by the substrate and therefore the reversible step 3 
of reaction 3.1, describing substrate binding to the enzyme, becomes less significant. In 
this case the effective rate equation can be written as  
                                                                0][Ekv cat=                                    (3.3) 
Therefore, in the case of a high substrate concentration, a change in substrate binding 
affinity upon mutation will directly affect the G‡cat and consequently the rate of the 
reaction.   
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According to equations 2 and 3, the change in the enzyme concentration caused by a 
change in folding free energy or dimer stability will also result in a change in the catalytic 
efficiency. In the present work, the binding affinity is calculated using a single trajectory 
MM-PBSA method [52-54]. Using this technique facilitates the analysis of a large 
number of mutations while primarily focusing on the affect of mutations on non-bonded 
interactions between the enzyme and the substrate/transition state analogue. The effects 
of mutations on monomer and dimer stability are not directly captured by the current 
method. 
The calculated binding affinity toward the transition state analogue (and substrate) 
does not provide any direct information about the activation energy of the catalyzed 
reaction; rather it provides information about the reduction in the activation energy 
relative to the uncatalyzed reaction.  For a general reaction, the activation energy of an 
uncatalyzed reaction can be related to the free energy of the substrate state (GS) and 
transition state (GT) as:  
                                                GTuncat - GSuncat   =G‡uncat      (3.4) 
And similarly for the catalyzed reaction,  
                                               GTcat - GScat   =G‡cat                         (3.5) 
The difference in the activation energies of the catalyzed and unanalyzed reaction is 




                   GT - GS = (GTcat – GTuncat) – (GScat - GSuncat)= G‡cat - G‡uncat            (3.6)    
The binding affinity toward the substrate and transition state analogue therefore can be 
directly related to the catalytic efficiency of the enzyme.   
The same approach can be extended to the study of the effect of a mutation on the 
catalytic efficiency of the enzyme, assuming the mutation does not significantly affect the 
fold stability of the active enzyme. For an enzymatic reaction taking place at vmax, and 
therefore at the effective rate constant of kcat, the effect of the mutation on the catalytic 
efficiency can be described as 
 ν(wt) / ν(mut) = exp(-(G‡cat(wt) - G‡cat(mut))/RT) 
        = exp(-((GT(wt) - GS(wt)) – ( GT(mut) -GS(mut) ))/RT)       (3.7)  
However, for a reaction taking place at a reduced substrate concentration as discussed 
earlier, assuming the mutation does not affect the stability of the folded protein, the affect 
of a mutation on substrate binding affinity is neglected and the reaction rate is primarily 
affected by changes to the transition state binding affinity. Under these conditions, it may 
be appropriate to calculate the effect of a mutation on the reaction rate using the 
following expression: 
 ν(wt) / ν(mut) = exp(-( GT(wt) - GT(mut) )/RT)             (3.8) 
As a result, the effects of mutations on enzyme activity can be ranked by changes in the 
ground state / transition state energy gap (at higher substrate concentrations) or changes 
in the transition state binding affinity (at lower substrate concentrations). In the current 
41

study, non-parametric correlations are determined between these energy changes and the 




1. Modeling initial structures and molecular dynamics simulation: 
The amino acid sequence of HIV-1 wild type protease was used as defined earlier 
[55]. The initial coordinates of HIV-1 protease consistent with the wild type sequence 
were taken from the crystal structure of an inhibitor bound complex at 1.80 Å resolution 
(PDB ID: 1HXW.pdb) [56]. The structures of the MA/CA substrate and tetra-coordinated 
water molecule were derived from another crystal structure of a catalytic aspartate 
mutated (D25N) HIV-1 protease (PDB ID: 1KJ4.pdb) bound to MA/CA [57]. The 
substrate and tetra coordinated water molecule were placed into the binding site of 
1HXW by superimposing the backbone of its active site (residues with atoms within 4.5 
Å of the ligand) on the corresponding atoms of 1KJ4 using CHARMM [36].  Another 
water molecule was placed at the catalytic center based on interatomic distances at the 
catalytic site determined in a previous study [58] (figure 3.2).  
The model of the MA/CA transition state analogue was created in compliance with 
the previously described tetrahedral anionic transition state [59]. This ground state model 
of the transition state structure has been used successfully in the previous computational 
studies of HIV-1 protease [60]. The catalytic site of the transition state analogue structure 
was built using the information from the crystal structure of the tetrahedral intermediate 
bound to HIV-1 protease [61] and the distances between heavy atoms were derived from 











Figure 3.2: The key atomic distances at the catalytic site in (a) substrate bound structures and (b) 
transition state bound structure used for modeling the initial structures. The distances are shown 





Amino acid point mutations were made to the wild type protease structure using the 
protocol developed by Feyfant et. al. [62].  This algorithm uses MODELLER [63] to 
predict the positions of the atoms in the new amino acid side chain using a knowledge-
based scoring function and molecular dynamics simulation methods. The mutations were 
made in the original inhibitor bound crystal structure (1HXW.pdb) before replacing the 
inhibitor with substrate into binding pocket as described previously.     
The atomic partial charges within the transition state analogue model were adopted 
from similar atoms in the Charmm22 parameter [64] and from a previous study [59]. The 
bond, angle, and dihedral parameters for the transition state analogue were also assigned 
from similar chemical systems present in the Charmm22 parameter set.  
All energy minimizations and molecular dynamics simulations were performed with 
the molecular mechanics package CHARMM [36], using the 22nd version of the protein 
force field [64]. A dielectric constant of 1 was used and the Lennard-Jones (L-J) 
interaction was truncated beyond 10 Å using a switch function. The Particle-Mesh Ewald 
(PME) method [65] was used to treat the electrostatic interaction with a 10 Å cutoff. A B-
spline order of 4 and real space Gaussian width of 0.34 -1 was used in PME calculation. 
The system was solvated in a truncated octahedron box of pre-equilibrated TIP3 water 
molecules [66], and the distance between any atoms of the protein to the nearest face of 
box was maintained to at least 10 Å. The system was neutralized and the salt 
concentration was maintained close to 150 mM by adding KCl. The water molecules with 
oxygen atoms closer than 2.6 Å to any atom of the solute were deleted. The bonds 
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involving hydrogen atoms were constrained using SHAKE [67] in CHARMM. All 
molecular dynamics simulations were performed in an NPT ensemble. The temperature 
of the system was kept on average at 300K using the Nose-Hoover thermostat. The 
constant pressure was maintained at 1 atm by the Langevin piston method [68]. Migration 
of the solute protein outside the primary solvent box was discouraged during the 
molecular dynamics simulation by a weak (0.5 kcal/mol) center-of-mass translational 
restraint using the MMFP module [69] of CHARMM. 
The systems (wild type and mutant HIV1 protease structures bound with substrate or 
the transition state analogue) were first minimized for 500 steps using the steepest 
descent (SD) algorithm, keeping solute atoms fixed in order to initially optimize the 
solute interactions with water. In the next step, a distance based harmonic restraint was 
applied between atoms at the catalytic site of the systems in order to restrain the distances 
to values given in figure 3.2, with a high force constant (1000 kcal/mol/Å2). The system 
was then minimized with the distance based harmonic restraints for 5000 steps using 
Adopted basis Newton-Raphson (ABNR) algorithm keeping only both chains of the 
protein fixed, allowing the substrate/transition state analogue and water molecule(s) to 
optimize with respect to the binding pocket under the influence of the restraint. In 
following steps, the distance based restraints were removed from the transition state 
analogue bound structures but kept for substrate bound structures. The systems were then 
minimized for 500 step using SD algorithm with harmonically restrained solute using a 
force constant of 50 kcal/mol/Å2 followed by 100 steps of SD minimization with a force 
constant of 10 kcal/mol/Å2 on the solute atoms.  
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The force constant associated with distance based restraint in the substrate bound 
structure was reduced to 200 kcal/molÅ2 before starting molecular dynamics, whereas no 
distance-based restraints were present for transition state analogue bound structure at this 
stage. The systems were gradually heated from 100K to 300K during 100 ps of 
simulation, with a 1 fs time step and a center of mass translation restraint. All atom-based 
restraints were then removed from the substrate bound structures, leaving only center-of-
mass restraints on the systems (both on substrate bound and transition state bound 
structures). The molecular dynamics simulation in an NPT ensemble at a temperature of 
300K was performed for equilibration (2-7 ns) and production (2 ns), using a 2 fs time 
step. Most of the structures were equilibrated within the initial 2 ns equilibration 
simulation after heating, however, for a few mutant systems the equilibration time was 
extended to 7 ns.  
2. MM-PBSA and entropy calculations 
Binding affinities were calculated using the MM-PBSA method. According to the 
MM-PBSA protocol, the binding affinity of a ligand to its receptor can be estimated by 
calculating the average change in gas phase energy Ugas, the average change in the 
solvation free energy Gsolv and the average change in the conformational entropy 
contribution to the binding –TS (17-19). In the present study, the free energy changes 
were estimated from single trajectories of protein-ligand complexes (single trajectory 
MM-PBSA) [52-54]. The flap motion in HIV1 protease is a relatively long time scale 
motion and therefore unbound protease cannot be accurately sampled with relatively 
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short (nanosecond time scale) simulations in explicit solvent [53, 70]. This is the primary 
reason to choose a single simulation MM-PBSA method over the frequently used three 
simulation MM-PBSA calculation in which separate simulation trajectories of protein, 
ligand and complex are used for free energy estimation. The single trajectory MM-PBSA 
calculation method has been successfully used with the HIV1 protease in previous studies 
[70, 71].   
      The gas phase energy (Ugas) in the single trajectory MM-PBSA calculation includes 
Coulombic energy (Gcoul) and van der Waals energy (GvdW). The gas phase energies were 
calculated from molecular mechanical energy function using Charmm22 [64] parameters. 
An internal dielectric constant of 4 and no cutoff was used while evaluating the MM 




     The polar part of the solvation energies (Gsolv-pol) was calculated using the Poisson-
Boltzmann (PB) equation.  The PBEQ module of Charmm was used to calculate 
electrostatic solvation free energy. The dielectric interface defined from the molecular 
(contact and reentrant) surface and a grid spacing of 0.4 Å was used. An internal 






      The non-polar part of solvation (GSA) energy was calculated using the solvent 
accessible surface area method, where the solvent accessible surface area (SASA) was 
calculated using a probe radius of 1.4 Å.  
                                               Gnp = SASA + b 
       The values of 0.00542 kcal/mol-1/ for surface tension coefficient , and 0.92 kcal/mol 
for offset b were used as suggested previously [72]. 
       The change in entropy estimation was performed using the VIBRAN module [73] of 
CHARMM, with the snapshots extracted every 40 ps from the production run. The 
normal mode analysis of the protein, ligand and protein-ligand complexes was performed 
in order to estimate the vibrational contribution to the change in entropy upon ligand 
binding. A distance dependent dielectric with definition of 4r was used while doing the 
normal mode calculations, where r is the pairwise distance between atoms. The 
electrostatic interaction was truncated beyond 12 Å using shift function.  The loss of 
transitional and rotational degrees of freedom upon protein ligand binding was estimated 
from the mass and moment of inertia of the protein [74], ligand and protein-ligand 
complex evaluated within the VIBRAN module of CHARMM.   
In calculating the Spearman correlation, the lowest rank was assigned to the mutant 
with the lowest experimental activity and the higher rank to the greater experimental 
activity. Similarly with the calculated activity, the lowest rank was assigned to the lowest 
calculated activity and higher rank to the larger calculated activity. The Spearman 
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correlation () between the experimental rank (xi) and the calculated rank (yi) was 
calculated as  



















P-values associated with the correlation coefficients were determined using the two-tailed 
test based on the t-distribution. 
The ability of the MM-PBSA method in estimating the absolute binding affinity has 
been questioned [53]. However, the MM-PBSA method has been successfully used in 
predicting relative binding affinities (25, 26). Based on this, a Spearman correlation was 




RESULTS AND DISCUSSIONS 
1. Rank correlation to the experimental data: 
The rank correlation between the calculated activities and the experimental activities 
were determined for 12 systems (G17E, M36V, N37S, G40E, K43R, M46V, M46T, 
G48E, L63P, L63V, N88D and wild type structure), available from a random 
mutagenesis activity analysis of the HIV-1 protease [47]. The calculated change in 
activation energy based on the change in substrate or ground state (GS) binding and 
transition state (TS) binding (using equation 3.7) show a strong and statistically 
significant Spearman correlation (r=0.81, r2=0.66, p=0.001) with the experimental 
activity (figure 3.3).  These results suggest that the affinity between the enzyme and both 
the transition state and the ground state substrate are factors for activity manipulation 
during course of evolution in HIV-1 protease. The MM-PBSA energies for the wild-type 
and each mutant are given in the appendix B.              
The correlation between experimental order of activity and the calculated activity is 
not significantly reduced (r=0.74, r2=0.55, p=0.005, figure 3.4) if only the change in 
transition state binding free energy is considered for the activity estimation (using 
equation 3.8). Mathematically, this is because the variance in TS binding due to the 
mutation (29.05 kcal/mol) is an order of magnitude larger than the variance in the GS 
binding (2.37 kcal/mol) for the mutants used in the experimental comparison.  Physically, 
the larger variance in TS binding upon mutation is consistent with its larger average 
binding free energy. Stronger binding affinity towards the transition state relative to the 
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substrate is expected because of the strong electrostatic interaction between transition 
state stabilizing residues in the enzyme and the transition state [75]. The change in 
transition state binding affinity appears to be a major cause of the change in activity 
resulting from mutation. However, as discussed previously, the in-vivo substrate 
concentrations experienced by HIV-1 protease suggest that substrate binding is also 








Figure 3.3: The rank correlation between experimental and predicted rank of activity considering 








Figure 3.4: The rank correlation between experimental and predicted rank of activity considering 
only transition state binding for activity calculation.  
54

Further analysis of the binding free energy components can provide more insight into 
role of electrostatic interactions. On comparing the components of the free energy of 
binding for the substrate and transition state, the relatively strong affinity for the 
transition state compared to the substrate arises primarily through electrostatic 
interactions (table AB1 in appendix B). Therefore, the electrostatic affinity toward the 
transition state distinguishes its binding mechanism from that of the substrate. Looking 
further into the components of the binding free energy, the change in calculated activity 
considering both the substrate and the transition state binding (equation 3.7) is mostly 
described by the change in the electrostatic component of transition state binding affinity 
(table 3.1). The significant contribution of electrostatic interactions toward the 
stabilization of transition states in enzymes has been demonstrated numerous times [76-
78]. In addition, these results are also consistent with a recent study [60] where the 
electrostatic interactions with the transition state were shown to be key factors in 
predicting drug resistant mutations in HIV-1 protease.   
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Table 3.1: MM-PBSA free energy decomposition describing the effects of 11 single amino acid 
mutants on substrate and transition state binding affinity as well as the change in activation 
energy (Gactive=Gt-Gs).  
Numbers in parentheses are standard deviations associated with averages.  
 
 
Free energy term Average change in 
substrate binding 
(Gs) 





Total Free energy -6.27(1.57) 5.49(5.39) 11.77(5.44) 
Total enthalpy (H) -1.91(1.92) 4.02(6.81) 5.93(8.01) 
van der Waals (GvdW) -0.06(2.35) 0.24(2.87) 0.31(3.025) 
Coulomb (Gcoul) -2.95(4.00) 3.60(7.36) 6.55(9.32) 
Polar Solvation (Gpol-solv) 0.95(3.77) 0.21(2.69) -0.74(4.29) 
Electrostatic (Gelec) -1.99(2.12) 3.81(6.32) 5.81(6.16) 
Chain Entropy (TS) 4.35(2.27) -1.47(2.39) -5.83(3.58) 
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In the present study, a simple and computationally tractable classical model approach 
has been shown to capture a significant portion of the information relevant to changes in 
enzyme activity. Using an endpoint free energy calculation method (MM-PBSA), it is 
possible to qualitatively predict the relative activity of 11 mutants and the wild type HIV-
1 protease. Prior work has demonstrated the utility of classical methods for assessing the 
effects of mutations on the function of enzymes [46, 79]. For instance, it has been shown 
recently that classical techniques for evaluating TS binding are capable of predicting the 
emergence of specific mutations in HIV-1 protease in response to drug treatment [60].  
While the availability of experimental data suggests HIV-1 protease as a favorable 
model system for the study of enzyme evolution, the low stability of the enzyme presents 
challenges. HIV-1 protease has a stability of ~2.2 kcal/mol [80], suggesting that a greater 
fraction of random single amino acid mutations may significantly disrupt the structure. 
This is consistent with the experimental observation that 2/3 of random mutations in 
HIV-1 protease result in an over 90% loss of activity [47]. The typical limitations of fully 
atomic molecular mechanics studies to ns timescale simulations limit the ability to detect 
changes in binding affinity that result in part from significant conformational changes in 
mutant enzymes. These limitations were exemplified by analyzing mutations in sequence 
positions 50-57, which are known to disrupt the structure of HIV-1 protease. 
The Spearman correlation between the activities determined from experiment and 
those determined from calculations decreases significantly (r2=0.19, p=0.16 using 
equation 3.7 and r2=0.21, p=0.13 using equation 3.8) when considering mutations in 
positions 50-57 (I50V, F53L, I54V, R57S and R57G). Mutations at positions 50, 53 and 
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54 have been shown to affect the stability of the active form of HIV-1 protease [81, 82]. 
In addition, the side chain of R57 has been shown to form several important contacts 
within the protease [83-85] consistent with this residue being important for fold stability. 
Substitutions at this position with a smaller side chain, which cannot compensate for the 
lost hydrogen bonds and salt-bridges, can have an adverse affect on the stability of the 
protease. This may also partly explain the existence of R57K as the only significant 
polymorphism of position R57 in HIV-1 protease [55]. This evidence suggests that some 
mutations act to disrupt the stability of the well-characterized folded conformation of 
HIV-1 protease leading to reduced activities. These instances will present challenges to 
traditional computational techniques for charactering the effect of random mutations on 
binding free energy and catalytic activity. 
2. Statistical analyses of 40 mutants on calculated activity 
While some approximations are clearly inherent to any modeling approach, statistical 
analyses of a broader dataset can provide information that is more robust than an 
individual measurement. In order to more broadly assess the physical mechanisms 
underlying the effect of mutations on enzyme activity, the study was expanded to include 
29 additional mutations that were found in a population of untreated patients based on an 
analysis of the HIV-1 protease sequence database from the Stanford University HIV drug 
resistance database [55]. Therefore in examining these mutations, naturally occurring 
polymorphisms are studied that are also less likely to result in a significant destabilization 
of the native fold and the subsequent loss of all catalytic activity. In other words, these 
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mutations are likely to be both relevant to the natural evolution of the enzyme and 
amenable to the analysis performed in this work. 
More insight into the binding mechanisms of the substrate and transition state 
analogue can be gained through analyses of the free energy components. As discussed 
earlier, the binding enthalpy to the transition state is more favorable than binding to the 
ground state primarily due to the electrostatic component (table 3.2). This is followed by 
some compensation in –TdS, since the stronger MM-PBSA energy is compensated by a 
weaker –TdS contribution to binding affinity (table 3.2). The mutations in general tend to 
weaken binding affinity to the transition state (figure 3.5). This appears to happen 
through a combination of energy terms. The most significant contributor appears to be the 
electrostatic component of the binding free energy (75% of mutants show weakened 
affinity in this term with an average change of 1.84 kcal/mol for all 40 mutants) and the 
binding entropy contribution, -TdS (87.5% of mutants show weakened affinity with an 
average change of 1.7 kcal/mol) as shown in table 3.2. The van der Waals term also 
appears to play some role with 57% of mutants showing weaker binding through this 
term resulting in an average change of 0.8 kcal/mol.  
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Table 3.2: Impact of 40 HIV-1 protease mutations on substrate and transition state binding.  
Free energy term Percent of mutations stabilizing 
substrate binding 
Percent of mutation 
destabilizing transition state 
binding 
Total (H) 100 80 
van der Waals (GvdW) 42.5 60 
Coulomb (Gcoul) 80 45 
Polar Solvation (Gpol-solv) 50 75 
Electrostatic (Gelec) 90 75 
Chain Entropy (TS) 95 87.5 
 Average change in substrate 
binding  
Average change in 
transition state binding  
Total (H) -6.79(2.69) 4.37(5.17) 
van der Waals (GvdW) -0.01(3.10) 0.89(2.83) 
Coulomb (Gcoul) -3.06(3.49) 0.09(5.59) 
Polar Solvation (Gpol-solv) 0.20(4.00) 1.74(2.59) 
Electrostatic (Gelec) -2.85(1.98) 1.84(4.41) 
Chain Entropy (TS) 4.09(2.11) -1.7(1.86) 
Nmbers in parentheses are standard deviations associated with averages.  
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Mutations also result in an increase in binding affinity toward the substrate (figure 
3.5). The increase in binding affinity for the MA/CA upon random mutation suggests that 
HIV-1 protease has evolved to bind less tightly to this substrate. This observation is 
further supported by the fact that enzymes in general have not evolved to bind the ground 
state (substrate) very tightly [75, 86, 87]. This could further be a consequence of the fact 
that HIV-1 protease is a promiscuous enzyme that is known to catalyze the hydrolysis of 
multiple sequences within the Gag-pol polyprotein. Weak binding toward any one 
substrate may be a consequence of frustration in evolving promiscuous activity. This 
weaker binding toward the substrates may also impact the protease’s catalytic efficiency 
as this enzyme is likely acting in a high substrate concentration environment. Under high 
substrate concentrations, weakened binding to the substrate (ground state destabilization) 
can theoretically result in a lower activation barrier and an increased catalytic rate [88]. 
An increase in the electrostatic component of the binding free energy is the major 
contributor (an average of -2.85 kcal/mol for all 40 mutants) toward the increase in 
substrate binding affinity for most (90%) of the mutations. The entropic term also plays a 
significant role in discriminating the effect of mutations on substrate and transition state 
binding. 95% of mutations show improved binding affinity toward the substrate with an 
average of -4.09 kcal/mol through entropic term (table 3.2), for all 40 mutants. As 
discussed earlier, these factors affecting ground state stabilization, along with transition 
state destabilization, could have direct implications for protease evolution by affecting 
the reaction rate. 
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Figure 3.5: (a). The change in binding affinity tow
ard the transition state for different m
utants 
relative to the w
ild type; (b). The change in binding affinity tow
ard the substrate for different 
m
utants relative to the w




3. Relation between change in substrate binding and transition state binding upon 
mutations 
The correlation between the calculated change in substrate and transition state 
binding for the 11 mutants that have been compared to experiment, as well as the larger 
set of 40 mutants, were determined. If the effects of mutation on substrate binding and 
transition state binding were highly correlated with some significant slope, mutations 
would have an attenuated effect on the previously mentioned energy gap and 
consequently a weaker effect on kcat and max. The lack of correlation (figure 3.6) 
indicates the evolution of the affinity to the ground state substrate and transition states are 
independent, possibly resulting in faster evolution of kcat or max. 
The weak correlation between a change in substrate binding and transition state 
binding upon mutation could also have implications in evolving activity and specificity 
independently.  When considering moderate or low substrate concentrations, the catalytic 
rate is determined by the kcat /KM. Under these conditions, the effective rate constant is 
insensitive toward changes in substrate binding affinity while remaining sensitive toward 
changes in transition state binding affinity. Alternatively, the specificity of the enzyme 
towards particular substrates can primarily be determined through substrate affinity [89]. 
Therefore, the ability to evolve ground state binding affinity and affinity towards the 
transition state independently through different mutations could also lead to the efficient 







Figure 3.6: The relationship between substrate binding and transition state binding upon 
mutations in HIV-1 protease. (a). Change in substrate binding affinity vs. change in transition 
state binding affinity compared to wild type for 12 variants used for comparison with experiment. 
(b). Change in substrate binding affinity vs. change in transition state binding affinity for 40 HIV-
1 protease variants. (c). Rank correlation of substrate binding affinity vs. transition state binding 
affinity for 12 variants used for comparison with experiment. (d). Correlation between substrate 
binding free energy and transition state binding free energy for 40 variants of HIV-1 protease. 
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4. Numerical model for HIV-1 protease catalytic process: 
Affinity calculations described here suggest that mutations in the wild-type HIV-1 
protease generally reduce the affinity toward the transition state or alternatively enhance 
the affinity toward the substrate. Posing this observation from the evolutionary 
perspective of mutations that lead to the wild-type, the calculations suggest that in the last 
stages of the evolution of HIV-1 protease, mutations may strengthen binding to the 
transition state or reduce the affinity toward the substrate. As described earlier, the 
strengthened binding toward the transition state can lead to enhanced activity by directly 
lowering the activation energy barrier.  However, based on the Michaelis-Menten 
mechanism, the effect of weakened substrate affinity on enzyme activity is dependent on 
the local substrate concentrations. In order to correctly rationalize the catalytic 
mechanism of HIV-1 protease under physiological conditions, a numerical solution to the 
Michaelis-Menten equation is derived using experimentally determined parameters 
associated with the activity of HIV-1 protease. The numerical model suggests that the 
concentration of the substrate in the immature virus particle (prior to activation of the 
protease) is significantly higher than KM and supports the theory that ground state 
destabilization could be a viable evolutionary mechanism for manipulating the activity of 
this enzyme.  
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Figure 3.7: Relationship between substrate concentration, change in substrate binding affinity and 
catalytic rate of the enzyme (on z-axis). 
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The reaction 3.1 can also be rewritten as:  
    (3.9) 
In this model, a mechanism was proposed that incorporates the characteristic flap motion 
of HIV-1 protease. The flaps within the HIV-1 protease are known to adopt different 
conformations depending on whether the enzyme is bound or unbound. In the current 
kinetic model, the opening and closing of the flaps in the apo state is assumed to establish 
a prior equilibrium before binding the substrate. The remaining mechanism follows the 
traditional Michaelis-Menten model where a steady-state concentration is assumed for the 
enzyme/transition state complex. The equilibrium constant of the flap (Kflap) was 
estimated to be 7.9X10-6, considering the free energy change of 7 kcal/mol upon flap 
closing based on a potential of mean force calculation [90]. Assuming the transition state 
barrier for substrate binding and unbinding to be 10 kcal/mol and 5 kcal/mol respectively, 
the rate constant for the substrate binding (k1) and unbinding (k-1) was calculated to be 
11303.96/Ms and 2.57/s respectively. The calculated rate constant k1 and k2 are found to 
be consistent to that estimated from NMR experiments, which suggest that k1 should be 
less than 20,000/Ms and k-1 should be a maximum of 10/s [91].  Therefore, in the current 
analysis, the simplified model of the substrate binding mechanism provides a reasonably 
good estimate of the rate constants for substrate binding. The calculated dissociation 
constant (Kd) using the present model was calculated to be 0.22 mM, which is in 
excellent agreement with another experimental observation that suggests the Kd should be 
approximately 0.2 mM [91]. Considering the activation energy of the reaction to be 18 
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kcal/mol [92], the kcat is estimated to be 0.48/s, also in agreement with experiment [93]. 
Therefore the KM turns out to be 0.27 mM, which is consistent with the suggested range 
of 0.01-0.5 mM [93]. Considering these calculated parameters, figure 3.7 demonstrates 
the relationship between the substrate concentration, the change in substrate binding 
affinity and the turnover rate for a standard 1 M enzyme concentration. The concentration 
of the enzyme will vary as virus matures; however, the value of enzyme concentration 
will affect the rate of the cleavage, but will not affect the relationship toward the ground 
state (substrate) binding affinity. 
Figure 3.7 indicates that at low substrate concentrations, as expected, changes in the 
ground state substrate binding affinity do not change the rate of the reaction. However, 
within a 100 nm diameter immature viral particle [94] comprised of 1500 gag and gag-
pol precursor molecules [95] (each of which contains at least 12 substrate cleavage sites) 
the concentration of only the MA/CA site described here is estimated to be approximately 
4.7 mM (higher than KM). At this substrate concentration, the figure 3.7 shows that 
changes in the substrate affinity can have a significant effect on the catalytic rate. This 
simplistic model suggests that ground state destabilization is a plausible physical 
mechanism contributing to the evolution of HIV-1 protease activity within the 




In the current manuscript, we have further demonstrated the potential of classical 
force fields in predicting enzyme activity by estimating the relative activities of a 
statistically significant number of HIV-1 protease mutants. In addition, we have 
attempted to further characterize the role of substrate binding during the evolutionary 
process of this important disease target. The significant correlation between the predicted 
activity and the experimental activity along with the numerical model developed to 
describe the activity of HIV-1 protease suggests that substrate binding could be a 
determining factor in manipulating enzyme activity during the evolution of HIV-1 
protease. We suggest that this ground state destabilization in the wild-type HIV-1 
protease can lead to enhanced catalytic efficiency in the high substrate concentration 
environment within the immature viral capsid. We further observed that changes in 
substrate binding and transition state binding due to mutation are not correlated. As 
discussed earlier, this could have implications in rapidly optimizing vmax and in more 









 The characteristic low frequency motions (dynamics) of an enzyme have been 
proposed to be critical for its catalytic efficiency. It has also been proposed that 
mutations, which disrupt the dynamics of an enzyme, could adversely affect its catalytic 
efficiency. Since the deleterious effects of mutations on the functional property of an 
enzyme can impose a significant constraint on its evolution, the present study examines 
the role of dynamics as a constraint on the evolution of HIV-1 protease. HIV-1 protease 
is a key target for AIDS therapy, and therefore, identification and characterization of 
constraints on its evolution is necessary for predicting drug resistant mutations. In present 
study, we are testing the hypothesis that sequence positions participating in correlated 
motions will result in substantially reduced catalytic activity in the HIV-1 protease when 
these positions are mutated. Testing this hypothesis will provide information related to 
the functional importance of correlated motions in HIV-1 protease activity and 
consequently whether the preservation of correlated motions is a constraint on its 
evolution. We have studied the role of dynamics as the constraint on the evolution of 
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HIV-1 protease by identifying highly correlated positions from molecular dynamics 
simulation, and comparing it to experimental activities of mutants at these positions. Our 
analysis was unable to identify any significant constraint that dynamics imposes on the 
evolution of HIV-1 protease. Consequently, explicit knowledge of dynamical features 
related to the catalytic property of HIV-1 protease doesn’t appear to be necessary for the 





The human immunodeficiency virus type 1 (HIV-1) protease is a virally encoded 
enzyme that catalyzes the cleavage of Gag and Gag-Pol poly proteins of the immature 
AIDS virus, and therefore plays an important role in its maturation process[16]. Due to its 
key role in the viral reproduction cycle, HIV-1 protease has been one of the major targets 
in AIDS treatment[96].  However, due to the inefficient replication process of HIV-1 
virus, different mutational variants of HIV-1 protease are rapidly produced and 
selected[5]. Some of these mutational variants result in resistance against protease 
inhibitors and are therefore preferably selected in the presence of drug. This process of 
selecting different mutational variants of HIV-1 protease can also be looked as enzymatic 
evolution. 
The evolutionary pathways and outcomes of an enzyme are significantly regulated 
by the constraints imposed from deleterious effects of amino acid mutations on functional 
properties. And therefore, identification and characterization of these evolutionary 
constraints is critical for prediction of evolutionary pathways and outcomes (including 
drug resistant mutations in the case of HIV-1 protease).  Recent experimental and 
theoretical studies suggest that the characteristic low frequency motions (dynamics) of 
enzymes are evolutionarily selected features that contribute to the catalytic activity of an 
enzyme[17, 18, 97, 98]. It has been further suggested that mutations that alter the 
dynamics of an enzyme could have deleterious effects on its catalytic activity[99], and 
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therefore dynamics can act as the constraint on its evolution.  However, the role of 
dynamics as a constraint on the evolution of HIV-1 protease has not been well 
characterized.  
Collective low frequency motions are inherent and characteristic to any protein 
structure[100]. These collective low frequency motions are often connected to low 
frequency normal modes and broadly termed as dynamics[101]. Since structure of an 
enzyme is well-known to be critical to its function and dynamics also follow from the 
structure, the protein dynamics has been thought to be an important factor in describing 
the enzyme function[100, 102]. Several NMR and theoretical studies have proposed the 
protein dynamics to be a determinant factor in molecular recognition, allosteric 
regulation, and enzyme catalysis[103-108]. More discussion about dynamical effect on 
the enzyme catalysis can be found elsewhere[98, 109, 110].  
One way to computationally characterize the effect of low frequency motions on 
enzyme activity has been the analyses of the covariance of displacement of residues 
within an enzyme[107]. Nanosecond (ns) time scale molecular dynamics simulations 
have been shown to capture most of the relevant correlated motions of the residues, 
including those identified from low frequency harmonic motions[111]. Therefore, 
analyzing the correlated motions of the residues from molecular dynamics trajectories has 
been in frequent practice to study the role of protein dynamics[112-117]. From the 
linearly correlated motions observed in molecular dynamics simulations, significantly 
positively correlated motions can result from long range coupling within the protein, but 
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can also be a side-effect of the neighboring secondary structures.  However, most of the 
highly negatively correlated motions are not the result of a trivial relationship between 
residues, and therefore have been hypothesized to be important dynamic features linked 
to enzyme activity[107]. It has been suggested that non-trivial correlated motions are 
evolutionary selected features that are important for enzyme function, and mutations in 
these negatively correlated regions can disrupt the enzyme function[107]. In further 
studies, it was postulated that a change in correlated motion caused by a mutation in any 
region of protein is related to a change in functional properties. Therefore change in 
linear correlation was considered as a parameter to address the effect of mutation on the 
function of any enzyme[118].  
In the present study, we have examined the role of dynamics as a constraint on the 
evolution of HIV-1 protease. Since the theoretical background of the dynamical effect on 
the catalytic efficiency is not very well established, one of the best approaches to study 
the role of dynamics is to examine its relationship with experimental mutant activities. 
This has been accomplished by studying the HIV-1 protease bound with one of its natural 
substrate (MA/CA).  The experimental data published by Martinez et. al.[47], where the 
effect of 98 mutations on the catalytic activity of HIV-1 protease toward its natural 
peptide substrate (MA/CA) has been determined, was used in conjunction with recently 
determined structures of HIV-1 protease bound to peptide substrates[57] and correlated 
motions within the relevant Michaelis complex were analyzed. The abundance of 
experimental information complemented with detailed molecular modeling makes 
possible a statistically significant study of the effect of correlated motions on enzyme 
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activity. In brief, the evolutionary importance of the positions possessing significant 
correlation has been examined by analyzing the experimental information about 
mutations at these positions and by comparing it with the experimental information about 
the mutations at different region of protein.  
 
 







1. Structure modeling and molecular dynamics simulation: 
 
The models of HIV-1 protease and MA/CA substrate complex were prepared 
using following methodology. The structures of the substrate MA/CA and tetra 
coordinated water molecule were derived from a crystal structure (PDB id: 1KJ4)[57] and 
placed into the binding pocket of another HIV-1 protease structure (PDB id: 1HXW)[56] 
that has an amino acid sequence consistent with the wild type definition[55]. The ligand 
and water were placed into the binding pocket of 1HXW by superimposing the backbone 
atoms of its active site residues (within 4.5 Å of ligand) on the corresponding atoms of 
1KJ4. Another water molecule was placed at the catalytic site using inter atomic 
distances from previous study[58] (figure 4.1). The modeled mutant structures were 
generated using tools within MODELLER[63], as suggested by Feyfant et. al.[62].  
The energy minimization and molecular dynamics simulation of different 
structures were performed with the molecular mechanics package CHARMM[36], with 
its 22nd version of force field[64]. The Particle-Mesh Ewald (PME) method was used to 
treat the electrostatic interaction with a dielectric constant of 1 and a cutoff of 10 Å. A B-
spline order of 4 and real space Gaussian width of 0.34 A-1 was used while performing 
PME calculations. The Lennard-Jones interactions were switched to zero beyond 10 Å. 
The structures were solvated in a truncated octahedron box of pre-equilibrated TIP3P 
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water molecules[66], with a minimum distance of 10 Å from any face of the box to any 
atom of solute. The salt concentration of the solvated system was maintained close to 
150mM by adding KCl ions, while keeping total charge of resulting system at zero. Any 
water molecules with their oxygen atom closer than 2.6 Å from any atoms of solute were 
removed from the system. Covalent bonds involving hydrogen atoms were constrained 
using SHAKE[67] during energy minimizations and molecular dynamics (MD) 
simulations. MD simulations were performed in the NPT ensemble, where temperature 
was maintained to an average of 300K using the Nose-Hoover thermostat and pressure 
was maintained to 1atm using the Langevin piston method[68]. The position of the 
Michaelis complex was restricted within the primary solvent box by a weak (0.5 
kcal/mol/Å2) center of mass translational restraint using the MMFP[69] module of 
CHARMM.     
The systems were first minimized for 500 steps using a steepest descent 
algorithm, keeping solute atoms fixed. Next, a distance based restraint between atoms at 
the catalytic site was applied with a force constant of 1000 kcal/mol/ Å2 (figure 4.1). The 
system was then minimized for 5000 steps using an adopted basis Newton-Raphson 
(ABNR) algorithm and both segments of protein were kept fixed in order to optimize the 
substrate interactions with the protein. At this stage, the distance based restraints were 
removed from the transition state bound structure, but kept for the substrate bound 
structure. The solute atoms were then harmonically restrained with a force constant of 50 
kcal/mol/Å2 and minimized for 500 steps using the SD algorithm, followed by 100 steps 
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of SD minimization with a reduced force constant of 10 kcal/mol/Å2, keeping the 
distance based restraint for the substrate bound structures only.  
 The force constant of the distance based restraint in substrate bound structures 
was reduced to 200 kcal/mol/Å2, and the system was gradually heated from 100K to 
300K during 100 ps of MD simulation. A 1fs time step was used during heating. In 
following steps, all atom based restraints were removed and the MD simulation of the 
system was performed for a further 2-7ns (equilibration time was different for different 
structures) for equilibration. Subsequently, a production simulation of 2ns for mutant and 















                           
Figure 4.1: The key inter atomic distances at catalytic site in MA/CA bound HIV-1 






2. Covariance analysis and comparison to experiment: 
 
The linearly correlated motions (linear correlation C(i,j)) between each sequence 
position are calculated with respect to the alpha carbons of individual amino acids as 








C     (4.1) 
Here, ri and rj are the displacement vectors for the atoms i and j, and the angle brackets 
denotes an ensemble average. 
Amino acid positions were then grouped based on the largest magnitude negative 
correlation observed for that amino acid position. Then the effect of mutations within this 
group of sequence positions on the activity of the enzyme (based on experimental 
measurements) was compared to the (average) effect of mutations on all positions. The 
goal here is to test the hypothesis that positions exhibiting negatively correlated motions 
are critical for enzyme function, and as a result these positions when mutated should 
result in more dramatic losses of enzyme activity than mutations elsewhere in the 
sequence. If the average effect of mutations on the negatively correlated group was more 
dramatic than that observed on average for all positions, then this would be evidence 
supporting the hypothesis that negatively correlated amino acid positions are particularly 
critical for enzyme function. The impact of mutations on a group of amino acid positions 
80

was determined by identifying the fraction of positions in the group that reduce the 
activity of the enzyme by 90% or more following a mutation based on experimentally 





RESULTS AND DISCUSSION 
 
Given that it is unclear exactly what degree of dynamic anti-correlation would 
constitute a cutoff for dynamical effects, a range of different values were examined from 
-0.19 to the maximum identified negative correlation (-0.37). The positions were grouped 
based on correlation coefficient and the fraction of “zero” activity positions were 
determined in each group. The group identified as any residue having an anti-correlation 
with some other position of  -0.19 contained all positions in our experimental dataset.  
Based on figure 4.2, we see that there is no steady increase in the fraction of 
“zero” activity positions as we focus on more negative correlation in motion. Moving 
from right to left in figure 4.2, we see no clear trend demonstrating that more negative 
correlated positions become more sensitive toward mutation. We further generated two 
groups of amino acid positions based on the wild-type correlated motion map. The first 
group (group 1) corresponds to amino acid positions that exhibit the strongest negatively 
correlated motions. The second group (group 2) of amino acid positions exhibits the 
weakest negatively correlated motions. The objective was to compare the effect of 
mutations within each group of amino acid positions on the activity of the enzyme to see 
if there was any significant difference between the two groups. The standard hypothesis 
would be that amino acid positions exhibiting the strongest negatively correlated motions 
(group 1) would exhibit the largest changes in activity upon mutation (since these 
positions are hypothesized to be critical for the function of the enzyme). The results seen 
82

in table 4.1 indicate that, the amino acid positions that show the most negatively 
correlated motions are not more sensitive toward mutation in comparison to positions that 


























































Figure 4.2: The relationship between the negative correlation coefficient and fraction of 




















Number of positions 
with “zero” activity 
Fraction of position 
that upon mutation 
result in 10% of 
wild type activity 




Cij<-0.31 28 22 16 73 
Group 
2 








In addition, we examined whether residues exhibiting positively correlated 
motions could be linked to the activity of the HIV-1 protease. Similarly, no significant 
trend is observed between the degree of positive correlation exhibited by an amino acid 
position and the impact on the activity resulting from mutating that position. In figure 
4.3, as we consider amino acids that have greater positively correlated motions, there is 
no trend demonstrating increase in the fraction of mutations that adversely affect the 








             





































Figure 4.3: The relationship between the positively correlation coefficient and fraction of 





By further examining the average percent activity of mutants associated with 
amino acid positions exhibiting positively or negatively correlated motions in the wild-
type enzyme, it remains apparent that there is no statistically significant relationship 
between the degree of correlated motion and the impact of the amino acid position on 
activity. Figure 4.4 demonstrates that as amino acid positions exhibiting greater negative 
correlated motions are considered, the average activity of the corresponding mutants does 
not significantly decrease. Similarly, in figure 4.5, as amino acid positions exhibiting 
greater positively correlated motions are considered, the average activity of the 
corresponding mutants does not significantly decrease. As shown in figure 4.4, these 
results indicate that positions exhibiting significant correlated motions are not more 











































Figure 4.4: The average percent activites of the mutants at positions exibiting highly negativly 






































Figure 4.5: The average percent activites of the mutants at positions exibiting highly positive 







To check if correlation to active site residues has any special importance, we 
repeated every part of our analysis considering only those correlated pairs where one of 
the pair of residues was within active site region (within 4.5 Å of ligand). As it can be 
seen in table 4.2, the positions with high correlated motions are not more critical for the 







Table 4.2: Summary of catalytic activities within correlation coefficient groups. (Only 


















result in 10% 




Group 1 Cij<-0.28 24 17 12 71 
Group 2 -0.12Cij 28 16 10 62.5 
The P-value for the significance of difference between fractions of “zero” activity 




To explore the connection between correlated motions and activity more directly, 
we quantified the degree of change in correlated motions upon single amino acid 
mutations. This “degree of change” in correlated motion is calculated as a squared 
Euclidian distance between the mutant and wild-type distance matrices where each 
element of the matrix corresponds to an orthogonal dimension. The degree of the change 
in the correlated motion upon mutation was then compared to the corresponding change 
in activity, as measured experimentally. The results indicate no significant non-
parametric correlation (r=0.192) between the change in correlated motions upon mutation 
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Figure 4.6: The correlation between rank of experimental activity and rank of degree of change in 





It should be noted that the dynamical anti-correlations observed in the HIV-1 
protease Michaelis complex (figure 4.7) were smaller in magnitude than those observed 
with other proteins. While relationship between correlated motion and activity in HIV-1 
protease remains dubious, this could be the result of relatively weak correlated motions 
observed in the HIV-1 protease/MACA  Michaelis complex. Other enzyme may exhibit 






                         
 






The present study suggests that dynamics, as characterized by the correlated 
motion of residues, does not play any significant role in describing the activities of 
experimentally studied mutants of HIV-1 protease. And therefore, dynamics does not 
appear to be a significant constraint on the evolution of HIV-1 protease. The inferences 
of present study are based on the analyses of available experimental information about 
HIV-1 protease, and do not necessarily provide evidence in favor or against of the 
proposal of dynamic influences on enzyme catalysis in general. However, our analyses 
suggest that the evolutionary outcomes of HIV-1 protease are not significantly regulated 









The deleterious effects of amino acid mutations on the fold stability of an enzyme 
can impose a significant constraint on its evolution. In the present study, we have 
assessed the role of fold stability on the evolvability (ability of enzyme to acquire 
mutations) of HIV-1 protease. We have used the FoldX protein design suite to estimate 
the effect of single point mutations on the fold stability of HIV-1 protease. In the first 
part of our study, we have examined the role of fold stability change resulting from single 
point mutations on the catalytic activity of HIV-1 protease. In the second part of our 
study, we have identified different patterns of mutations from analyses of the HIV-1 
protease sequence database, and compared these patterns to the change in fold stability 
caused by relevant mutations. We have observed a significant tradeoff between 
evolvability and fold stability for HIV-1 protease, and therefore, our study suggests that 





The epidemic acquired immunodeficiency syndrome (AIDS) is caused by the human 
immunodeficiency virus (HIV)[119]. Two species of HIV have been identified (HIV-1 
and HIV-2), out of which HIV-1 is the best characterized and studied due to its extensive 
prevalence among patients. HIV-1 is a retrovirus and the genetic information for the 
reproduction of this virus is encoded in the form of RNA[16]. Once this virus enters into 
the living cell, the structural components of virus are produced in subsequent steps with 
the assistance of two virally encoded enzymes, viz. HIV-1 reverse transcriptase and HIV-
1 integrase, along with the help of cellular machinery. At the final step of reproduction, 
the Gag and Gag-Pol polyproteins of the new virus are cleaved into functional proteins 
with the help of another virally encoded enzyme known as the HIV-1 protease, thus 
producing the mature virus[16]. Due to its key role in the viral maturation process, the 
HIV-1 protease has been a primary therapeutic target in the treatment of AIDS[96]. 
However, the replication process of HIV-1 protease is very inefficient and erroneous. The 
relatively high replication rate of the virus (108-109 virions/day) complimented by the low 
replication fidelity (5x10-4 mutations per nucleotide per generation) results in the rapid 
accumulation and selection of different mutational variants of HIV-1 protease[5]. Some 
of these variants are drug resistant and are preferably selected in the presence of protease 
inhibitors. This process of acquiring mutations within HIV-1 protease can also be seen as 
an evolutionary event.  
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The deleterious effects of mutations on the functional properties of an enzyme act as a 
major constraint on its evolution. The change in fold stability (Gfold) of an enzyme 
upon mutation is one such constraint[22]. In a number of previous experimental and 
theoretical studies, it has been shown that the majority of single point mutations have a 
destabilizing effect on a protein[120-123]. In previous theoretical studies, which were 
performed with all possible mutations within different proteins using experimentally 
validated FoldX algorithm[124], 70% of mutations were found to have a destabilizing 
effect with more than 20% mutations having destabilizing effect of >2 kcal/mol[125]. In 
another theoretical study examining 246 new-function (function altering) mutations 
observed in directed evolution experiments performed on 22 different enzymes, it was 
found that the new-function mutations on average have destabilizing effect (Gfold = 
0.9kcal/mol) on enzyme, which was close to average destabilization effect (Gfold = 1.3 
kcal/mol) caused by every mutation observed in directed evolution[126]. 
The fold stability of HIV-1 protease, and its ability to bind substrate and 
corresponding transition state can be considered as one of the most important constraints 
on its evolution. In order to successfully accommodate an amino acid mutation in the 
HIV-1 protease sequence, these constraints should be satisfied so that HIV-1 protease can 
remain catalytically active and perform its essential function. The role of substrate and 
transition state binding as constraints on the evolution of HIV-1 protease have been 
characterized in previous studies, where it has been shown that drug resistant mutations 
don’t have a significant effect on the substrate and transition state binding [127-129]. 
These observations about drug resistance mutations provide evidence of selection for 
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mutations that don’t significantly affect substrate or transition state binding. However, 
the role of fold stability in the evolution of HIV-1 protease has not been very well 
quantified or discussed. 
In the present study, we have examined the relationship between Gfold and the 
evolvability (ability of enzyme to acquire mutations) of HIV-1 protease. The 
experimentally validated FoldX algorithm[124] was used to estimate Gfold. As 
discussed previously, the FoldX algorithm has limited accuracy in predicting the stability 
change of individual mutations, but performs very well in predicting the average change 
in stability for a group of mutations [125, 130]. Therefore, we have looked for the 
average stability change of a group of mutations in every part of our study. We have first 
estimated Gfold for all possible mutations in HIV-1 protease and examined general 
characteristics of the distribution of amino acid mutations over Gfold values. To 
examine the role of Gfold in the effect of random mutations on the HIV-1 protease 
activity, we have divided the mutants into three groups based on their experimental 
activity values and estimated average Gfold for each of these three groups. In order to 
get more insight into the effect of Gfold on the evolvability of HIV-1 protease, we have 
next determined the amino acid position entropies, mutation frequencies and the 
symmetric uncertainty between residue pairs from the analyses of large number 
sequences data taken from both drug treated and drug naïve patients. We have used 
symmetric uncertainty as the measure of mutational correlation between residue pairs. 
The patterns in position entropies, mutation frequencies and symmetric uncertainties 
were then rationalized using Gfold information from the relevant mutations. In brief, 
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with the help of experimental information, bioinformatics analysis and a computational 
fold stability change estimation technique, the present study suggests that the fold 





The general equation describing the enzymatic reaction can be written as 

(5.1)
The k1 and k-1 are rate constants for substrate binding and unbinding process, and kcat is 
the rate constant for the catalysis step.  
For enzyme catalyzed reactions, the Michaelis-Menten formulation provides a 
generally accepted quantitative description of enzyme catalysis. According to the 











=      (5.1) 
Where, [E]0 and [S]0 represent  the initial concentrations of enzymes and substrate,  and     
11 /)( kkkK catM −+=  
In the case of HIV-1 protease, two monomeric units (M) join to form the active 




The kd1 and kd-1 represent the rate constant for the dimerization process. The rate of the 

















−      (5.2) 
 
If it is assumed that mutations within the enzyme only affect the fold stability and 
every other parameter describing the reaction rate are insensitive to mutations, then 
mutations will affect the reaction rate through the initial concentration of enzyme ([E]0 or 
[M]0). Assuming enzyme folding process (step 1 in equation 5.1) establishes a prior 
equilibrium, the relationship between concentrations of folded and unfolded enzyme can 
be written as Kfold =   [E]/[U] , where [E] and [U] are the concentrations of folded and 
unfolded enzyme and K is the equilibrium constant of the reaction which is related to the 
folding free energy (Gfold) by Gfold=-RTlnKfold. A mutation which changes the fold 
stability by Gfold, will result into new folded ([E’]) and unfolded ([U’]) concentrations 
of enzyme, which are related by the new equilibrium constant K’fold (Gfold+Gfold=-
RTlnK’fold). Since the total concentration of enzyme remain unchanged ([E]+[U] = 
[E’]+[U’]), we can derive a relationship between concentration of folded conformations 
at two different free energy values, which is 
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The extent of the effect on the reaction rate will depend on the impact of the 
mutation on fold stability and the intrinsic fold stability of the enzyme. In previous 
studies, it has been shown that most random mutations have destabilizing effect on 
protein. As shown in figure 5.1(a), the catalytic activities of comparatively stable 
enzymes are less sensitive to the stability changes caused by amino acid mutations, and 
the enzymes which are comparatively less stable are very sensitive to the stability change. 
In the case of HIV-1 protease type of systems, where two monomeric units join together 
to form the active enzyme, the reaction rate is even more sensitive to the change in 
stability compared to the monomeric proteins (figure 5.1(b)).  
The fold stability of monomeric HIV-1 protease has been estimated to be ~1.05 
kcal/mol[23]. The stability of HIV-1 protease is very marginal compared to most of the 
known proteins which are found to be stable by 5-15 kcal/mol[134]. As shown in the 
figure 5.1(b), the catalytic activity of HIV-1 protease will be extremely sensitive to the 
change in fold stability caused by the mutations and therefore, fold stability can act as the 
major constraint in the evolution of HIV-1 protease.       




            
Figure 5.1: Graphs showing relationship between fold stability of enzyme (Gfold), its % activity and change in fold stability (Gfold) for 
(a) monomeric enzymes (b) HIV-1 protease type enzymes which are active as a dimer.  [For figure 1(a) %Activity = f *100, and for figure 





1. The Gfold distribution of HIV-1 protease: 
 
The general characteristics of the effect of all possible single amino acid mutations 
and single nucleotide mutations on the fold stability were observed by analyzing the 
Gfold values upon these mutations. The characteristic shape of the distribution curve of 
all possible single amino acid mutations over Gfold values (figure 5.2a) is similar to 
what has been observed with other proteins[125]. However, the distribution is shifted 
indicating a greater degree of destabilization compared to other proteins. A total of ~18% 
single amino acid mutations were predicted as stabilizing for HIV-1 protease, compared 
to ~30% for the proteins examined in previous studies[125]. This suggests that the HIV-1 
protease has more tendencies to be destabilized upon amino acid mutations compared to 
other proteins.  About 50% of single amino acid mutations were found to have 
destabilizing effect of more than 1 kcal/mol (the fold stability of HIV-1 protease is ~1.05 
kcal/mol). The distribution curve of all possible single nucleotide mutations over Gfold 
is remain very similar to distribution curve of single amino acid mutations, with ~17% 





                      
      
 
Figure 5.2: The distribution curve of Gfold values of (a) all possible 19 mutations at each amino 
acid positions, (b) all possible single nucleotide mutations in gene encoding HIV-1 protease. The 





2. Role of Gfold on the catalytic activity of random mutations: 
 
The role of Gfold on the catalytic activity of HIV-1 protease was examined by 
exploring its relationship with activities of experimentally studied random 
mutations[135]. For these mutations, we have compared the activities values determined 
experimentally with predicted effects on protein stability. The mutations were divided 
into three groups based on their experimental activities. The group I represent mutants 
with 0% activity, group II represents mutants with 0 to ~10% activity and group III 
represents mutants with >10% activity. The average Gfold for all three groups of 
mutants were then estimated using FoldX. As shown in the table 5.1, the average Gfold 
for the group III mutations (0.62 kcal/mol) is significantly lower compared to the average 
Gfold value (1.71 kcal/mol) for Group I mutations and average Gfold value (1.55 
kcal/mol) for Group II mutations. This suggests that the loss in activity for group I and 
group II mutations is significantly driven by the loss in fold stability. Further, FoldX has 
predicted 20% mutations as stabilizing within group III, compared to 2% in group I and 
5% in group II, which further implies that the distribution for group I mutations over 























Group I A = 0 50 0 1.71(0.19) 2 
Group II 0 <A  ~10 20 ~3.3 1.53(0.23) 5 
Group III A > 10 35 ~69.1 0.63(0.15) 20 
-The standard errors of mean associated with averages are given in parenthesis next to the 
value.   
-The P value for the significance of the difference between means of group I and group 
III is 0.000062 (d.f.=83), and between means of group II and group III is 0.00145 






3. Correlating Gfold with position entropy: 
 
The role of stability in describing the position variability (entropy) in the HIV-1 
protease sequence was examined by estimating the effect of mutations on fold stability 
and comparing this to experimentally determined sequence entropies. We first 
determined the amino acid position entropies for HIV-1 protease sequence by analyzing 
the protease sequences obtained from both, drug treated and drug naive patients[55]. We 
excluded the positions 1 to 4 and 96 to 99 from our analysis as terminals of HIV-1 act as 
the substrate for itself[133], and therefore conservation of these positions are less likely 
to be driven by stability. The amino acid positions within HIV-1 protease were first 
grouped based on entropy values (group I with entropy value <0.1, and group II with 
entropy value 0.1). We have then identified the mutations with the least destabilizing 
effect from the data of Gfold for all 19 mutations of each amino acid position within 
HIV-1 protease using FoldX. The average change in Gfold for these least destabilizing 
mutations within each position entropy group was then estimated (table 5.2).  
As reported in the table 5.2, the positions with high sequence entropy are more likely 
to mutate without significantly undermining the ability of protease to fold to its 
catalytically relevant structure, compared to the group of positions with comparatively 
low entropies. In these conserved positions, a mutation is more likely to destabilize the 
protease to an extent where it will significantly lose its activity.  This suggests that 
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Average change in 
Gfold for two least 
destabilizing 
mutations (kcal/mol) 
Average change in 




% of position 




Group I <0.1 30 0.63(0.33) 0.82(0.26) 0.96(0.22) 33.3 
Group II 0.1 56 -0.13(0.12) 0.04(0.09) 0.19(0.08) 55.36 
-The standard errors of mean associated with averages are given in parenthesis next to the value. 
- The P value for the significance of the difference between means of group I and group II (a) for least destabilizing 
mutations is 0.0108(d.f.= 84), (b) for two least destabilizing mutations is 0.00073(d.f.= 170), and (c) for three least 
destabilizing mutations is 0.000093 (d.f.= 256). 
- Five positions in group I were found to have Gfold values for least destabilizing mutations >10kcal/mol, and were 
excluded from the analysis (see the method section)
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4. Effect of Gfold on the frequency of mutations: 
 
We further examined the role of Gfold on the evolvability of HIV-1 protease by 
exploring the relationship between the frequency of a mutation and its effect on the fold 
stability of HIV-1 protease. The frequency of every mutation in HIV-1 protease was 
evaluated using the HIV-1 protease sequence database from treated and untreated 
patients[55]. The positions from 1 to 4 and from 96 to 99 in HIV-1 protease were 
excluded from our analysis as these amino acids act as the substrate for itself, and 
therefore the fold stability is not the prime factor for their conservation. We divided all 
mutations observed in the database based on their frequencies of appearance (group I 
with frequency >0.008, group II with frequency 0.008 but >0, and group III of the 
mutants which were not observed in sequence analysis). The average Gfold for the 
mutations within each group was estimated using FoldX. As shown in table 5.3, the high 
frequency mutations were found to be less destabilizing on average compared to the low 
frequency mutations. The average destabilizing effect of zero frequency mutations were 
observed to be highest. This analysis further suggests that the fold stability plays a key 





















Group I f >0.008 104 0.64(0.11) 25 
Group II 0.008  f >0 533 1.31(0.07) 18.01 
Group III f = 0 1037 1.95(0.06) 13.89 
-The standard errors of mean associated with averages are given in parenthesis next to the 
value. 
- The P value for the significance of the difference between means of group I and group 
II is 0.000074(d.f.= 635), between I and III is <0.000001(d.f.= 1139), and between II and 








5. Correlated mutations and stability effect. 
 
A high degree of cooperativity has been proposed among mutations in HIV-1 
protease, which is reflected as the covariance of these pairs in sequence database[136, 
137]. In several previous studies regarding mutational pairs, it has been proposed that one 
of the mutations in a pair compensates for the destabilizing effect of the other 
mutation[126, 138, 139]. In order to study the role of stability on the covariance of the 
mutations in HIV-1 protease, we have first identified the pairs with high symmetric 
uncertainty value (>0.05) from the sequence database of treated and untreated patients. 
Currently, no computational algorithm has been extensively validated for predicting the 
effect of double mutations on fold stability. Therefore, our ability to fully address the role 
of fold stability on the observed covariance of mutational pairs in sequence database is 
limited. To examine the role of fold stability on the covariance of mutational pairs by 
estimating Gfold upon single point mutations, we ranked the mutations within each pair 
based on its conditional probability, and formed groups of higher conditional probability 
(group I) and lower conditional probability (group II) of mutations from each pair. As 
demonstrated in a previous study, mutations with higher conditional probability are more 
likely to appear first during evolution, compared to the second mutation in a pair[139].  
As shown in the table 5.4, the group I mutations (with high conditional probability) 
are less destabilizing (~16% mutations being stabilizing) compared to the group II 
mutations (mutations with low conditional probability). The group I mutations, however, 
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do not demonstrate a complete compensation of the destabilizing effect caused by the 
group II mutations. Since we have studied only single point mutations, and a strong 
epitasis has been observed among the mutations of HIV-1 protease[140], our ability to 
address the effect of stability on the covariance of mutations is limited. However, these 
results indicate that mutations appearing first could compensate for the destabilizing 
effect of the second mutation in a pair, and therefore, one of the pair mutations can play a 



















Group I 137 0.72(0.08) 16.06 
Group II 137 1.69(0.13) 8.76 
-The standard errors of mean associated with averages are given in parenthesis next to the 
value. 
- The P value for the significance of the difference between means of group I and group 






In order to fully explore the role of fold stability as a constraint on evolution of HIV-1 
protease, we have extended our study beyond naturally selected mutations (drug resistant 
mutations and mutations observed during directed evolution). Naturally selected 
mutations appear after satisfying the constraints on evolution, and therefore, any study 
performed with these mutations to identify and characterize the constraints on evolution 
is likely to have limited success. In every part of the present study, we have compared the 
effect on fold stability caused by evolutionarily more favored mutations (high activity 
mutations, high entropy positions, high frequency mutations and high conditional 
probability mutations) to the effect on fold stability caused by evolutionary less favored 
mutations (low activity mutations, low entropy positions, low frequency mutations and 
low conditional probability mutations).  In each case the evolutionary more favored 
mutations were observed to have less destabilizing effect compared to the evolutionary 
less favored mutations. Results of this study suggest that the Gfold plays a key role in 
describing the relative activities of the HIV-1 protease mutations, and therefore fold 
stability imposes a significant constraint on the evolution of HIV-1 protease.  
As mentioned previously (figure 5.1), the sensitivity of the catalytic activity of an 
enzyme toward Gfold depends on its fold stability. Consistent with this fact, a previous 
study performed with relatively stable proteins has observed no distinct tradeoff between 
new function and stability[126]. However, in the case HIV-1 protease which is stable by 
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only ~1.05kcal/mol[23], we have observed a significant tradeoff between stability and 
evolvability. This also suggests that every time a drug resistant mutation appears, the 
stability constraint has to be satisfied, along with reducing the affinity for inhibitor and 
maintaining the affinity for substrate and transition state. And therefore, in future attempt 
to predict the drug resistant mutations, stability should also be taken into consideration. 
We have used FoldX to estimate the average Gfold for groups of mutations in every 
part of our study. In several previous studies, it has been shown that computational 
algorithms (including FoldX) have limited accuracy in predicting the Gfold for 
individual mutations[130]. However, they perform very well in estimating the average 
Gfold for several mutations [124, 125, 130]. The ability of FoldX to accurately predict 
the average Gfold for large set of mutations has been successfully utilized in several 
previous studies [125, 126]. More discussion about FoldX and its predictive ability can 
be found elsewhere[124]. 
As our results suggest that fold stability imposes a major constraint on the evolution 
of HIV-1 protease, accurate knowledge of the change in fold stability upon amino acid 
point mutation(s) appear to be key information in predicting evolutionary outcomes (such 
as drug resistant mutations) of HIV-1 protease. Therefore, our study not only indicates 
that fold stability act as a major evolutionary constraint, but also emphasizes the potential 





The methodological details of present work can be classified in to two parts. In one 
part, we performed sequence analyses on HIV-1 protease to calculate symmetric 
uncertainties between pairs of sequence positions, position entropies of sequence 
positions and frequencies of specific mutations. In the other part of our study, we 
estimated changes in fold stability (Gfold) upon single point amino acid mutations. 
 
1. HIV-1 protease amino-acid sequence analyses 
 
All nucleic acid sequences corresponding to the HIV-1 subtype B protease obtained 
from both treated and untreated patients were downloaded from Stanford HIV RT and 
Protease Resistance Database[55] on February 25, 2010. In case of multiple sequence 
entries from the same patient, only the most recent data entry for that patient is included 
in the analysis.  
(a). Position entropy:  
The entropy (H) of a position x was calculated as  
 −=
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Where, xi is the mutational variant at position x.  
(b). Symmetric Uncertainty:  
  Symmetric uncertainty is a normalized version of the mutual information and 
varies between 0 and 1. The symmetric uncertainty [U(x,y)] between two random 
variables (positions) x and y can be expressed as  







The I(x,y) in the above equation is the mutual information between random variables x 
and y, and can be expressed as  
   ),()()();( yxHyHxHyxI −+=  
Where,    −=
i iallx ally
iiii yxPyxPyxH ),(log),(),( 2   is the joint entropy between positions 
x and y.     
 
2. Estimation of fold stability change upon mutations. 
 
The changes in fold stability (Gfold) of HIV-1 protease upon single point amino 
acid mutations were estimated using the protein design tool FoldX (version 3.0)[141]. We 
followed exactly the same procedure to estimate Gfold as has been used in previous 
studies [125, 126]. We have chosen a high resolution crystal structure of the monomeric 
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HIV-1 protease for our study (PDB ID: 2PC0[142]). We first optimized the crystal 
structure using the repair function of FoldX. The crystal structure had a Q7K mutation, 
which was back mutated to the wild type sequence using FoldX. In the next step, 
structures corresponding to all possible single point mutations were generated, and 
corresponding energies were estimated using the position scan function of FoldX. The 
Gfold values corresponding to each mutation were estimated by comparing the energies 
of mutant structures with energies of corresponding wild type structures. We have used a 
conversion formula [Gfoldexperimental = (GfoldFoldX + 0.078)/1.14] to adjust the FoldX 
energies as suggested in previous studies[125, 126]. Any mutations showing an 
unphysically high Gfold (>10 kcal/mol) were excluded from our analysis. There were 
55 such mutations (2.9% of all possible mutations), which were excluded from out study. 
P-values used to determine the significance of the difference between average Gfold 











The development of a molecular level understanding of drug resistance through -
lactamase is not only critical in designing a newer generation antibacterial agents, but 
also in providing insight into evolutionary mechanisms of enzymes in general. In the 
present study, we have evaluated the effect of four drug resistant mutations (A42G, 
E104K, G238S, and M182T) on the cefotaximase activity of the TEM-1 -lactamase. 
With the help of computational methods, we have been able to correctly identify the 
relative order of activities for these four single point mutants compared to wild type.  In 
our further analyses of structural properties, we have observed that the changes in 
catalytic efficiency for mutant enzymes are correlated to structural changes within the 
binding site. Based on the energetic and structural analyses of the wild type and mutant 
enzymes, structural rearrangement is suggested as a mechanism of evolution of drug 
resistance through TEM -lactamase.  The present study not only provides a molecular 
level insight into the effect of four drug resistant mutations on the structure and function 
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of the TEM -lactamase, but also sets up the direction for future molecular level analysis 





-lactam antibiotics are the antibacterial agents that inhibit bacterial growth by 
inhibiting cell wall synthesis[6]. The first drug in this class was Penicillin G 
(benzylpenicillin), which was introduced into clinical practice during 1940s[25]. 
However, soon after Penicillin G was brought into regular practice to treat bacterial 
infections, bacteria was found to develop resistance against this drug by secreting an 
enzyme called -lactamase[6, 25, 26]. -lactamase is believed to evolved from Penicillin-
binding-proteins (PBPs)[144-147], which are the natural targets of the -lactam 
antibiotics. There is another view about the evolution of serine -lactamase which 
suggests that these are ancient enzymes, and originated over two billion years ago[148]. 
The -lactamase catalytically hydrolyzes the -lactam ring and therefore inactivates this 
class of antibiotics. Based on the sequence similarity, -lactamase has been subdivided 
into four classes[144, 149, 150].  Class A, C and D are the active site serine enzymes, and 
class B requires metal for its catalytic activity. The class A TEM -lactamase is one of 
the most commonly found plasmid-mediated -lactamase within Gram-negative 
bacteria[151], and our further discussion will be focused on TEM -lactamase.  
 The TEM -lactamase uses the hydroxyl group of its active site serine residue 
(Ser70) as the key functional group for catalyzing the hydrolysis reaction[152]. Once the 
-lactam antibiotic is accommodated into the binding pocket of this enzyme, acylation, 
deacylation and product release are the three steps through which hydrolysis takes 
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place[153]. Several different mechanisms for this reaction have been proposed. 
According to one of the latest proposed mechanisms for the hydrolysis of 
benzylpenicillin[152], the key acylation reaction believe to take place in two steps. In the 
first step, indirect activation of nucleophile Ser70 takes place by Glu166. The Glu166 
abstracts a proton from a bridging water molecule, and the resultant hydroxyl causes 
deprotonation of Ser70. This deprotonated Ser70 attacks the carbonyl group of the -
lactam ring, thus forming a tetrahedral intermediate[152]. In the second step of acylation 
where the acyl-enzyme complex is formed from the tetrahedral intermediate, the leaving 
thiazolidine nitrogen is protonated by Ser130, which is reprotonated by Glu166 via 
Lys73[152]. These reactions result in the complete breakdown of the lactam bond. In a 
kinetic study of the hydrolysis reaction of the -lactamase against benzylpenicillin, the 
rate constants for every step of the hydrolysis reaction were experimentally 
determined[154]. It was found that no single rate-determining step exists for -lactamase 
catalyzed hydrolysis raction of benzylpenicillin[154]. The rate constants for all three 
steps of hydrolysis (acylation, deacylation and product release) were determined to be 
approximately the same, and the overall hydrolysis reaction was found to be diffusion 
controlled.  It is therefore concluded that -lactamase functions as a fully efficient 
enzyme[144, 154].   
 In order to evade the catalytic action of the -lactamase, several new classes of -
lactam antibiotics were designed with the aim of synthesizing an antibiotic that cannot be 
hydrolyzed. Cefotaxime is one of these later generation drugs (third generation 
cephalosporin -lactam antibiotic) that cannot be efficiently hydrolyzed by the TEM-1 -
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lactamase[151]. One of the strategies in designing these newer generation drugs was to 
make their side groups around the -lactam ring bulkier so that they cannot fit into the 
binding pocket of -lactamase without compromising its ability to bind the PBPs. It is 
believed that the bulkier groups around the -lactam ring in cefotaxime compared to the 
benzylpenicillin (figure 6.1) prevent its binding to the -lactamase, and therefore prevent 
its hydrolysis. However, later it was found that five point mutations within TEM-1 -
lactamase gene produce a variant of -lactamase which is capable of hydrolyzing the 
cefotaxime and therefore causes drug resistance[27, 28]. This consists four missense 
mutations[155] [A42G, E104K, M182T, and G238S] and one 5’ non-coding 
mutation[156] [g4205a]. Since the reactive part [-lactam ring] of cefotaxime is identical 
to that of the benzylpenicillin (figure 6.1), and the hydrolysis reaction catalyzed by -
lactamase is diffusion controlled, the cefotaxime binding process can be considered as the 
rate limiting step in the cefotaximase activity of -lactamase. And therefore, it can be 
thought that during the evolution of improved activity against cefotaxime, -lactamase 
increases its affinity for the cefotaxime. Since the core structure of the -lactam ring 
remains unchanged in cefotaxime from benzylpenicillin, the activation energies for the 
reaction can be thought to be approximately same as in the case of benzylpenicillin. This 
hypothesis of substrate binding being rate limiting step in the case of the -lactamase 
catalyzed reaction has already been experimentally verified with cephaloridine[157] 
(another 3rd generation cephalosporin -lactam antibiotic). In the experimental study, the 
reaction of mutant -lactamase was studied against benzylpenicillin and cephaloridine, 
and it was found that the acyl-enzyme structures do not account for the faster hydrolysis 
127

of the benzyl penicillin[157]. It was suggested that the relative activity towards 
benzylpenicillin and cephaloridine for class A -lactamase must be determined prior to 















         
 Benzylpencillin          Cefotaxime  
 
Figure 6.1:  The chemical structures of benzylpenicillin and cefotaxime.  
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Development of drug resistance by increasing the catalytic activity of -lactamase 
against cefotaxime can also be seen as the evolutionary event within a background of an 
external pressure (i.e. the presence of a drug)[25, 158]. And therefore, this process of 
developing drug resistance in bacteria can be utilized to address evolution related 
questions. Considering these facts, the effect of the genetic background on the phenotypic 
consequence of a mutation (also termed as the “Epistasis”) has been experimentally 
addressed using TEM -lactamase and cefotaxime as a system[29]. There are 5! = 120 
possible mutational trajectories (considering all five point mutations in the gene, and 
assuming only single mutations take place at each step) through which the suboptimal 
allele (wild type -lactamase) can evolve to an optimal allele (five point mutated -
lactamase). In the case of “Sign Epistasis”, all mutational trajectories would not be 
assessable with equal probability[8].  In the experimental study, all possible mutational 
trajectories from the suboptimal to optimal allele were constructed and their probability 
of realization was assessed[29]. It was found that 102 of the 120 mutational paths were 
selectively inaccessible, and only 18 paths were found to increase in resistance and 
fitness at each step and therefore accessable to Darwinian selection[29]. This experiment 
has provided concrete evidence of “Sign Epistasis” and demonstrated constraints in 
evolution[159].  
 From the above discussion, it is clear that the development of a molecular level 
understanding of -lactamase evolution has a great deal of implications in the 
development of better antibiotics, along with providing more general insight into enzyme 
evolutionary mechanisms. In the present study, we have studied the effect of first line of 
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mutations in evolutionary trajectory [A42G, E104K, M182T, and G238S] as studied in 
the previous experiment, on the cefotaximase activity of TEM-1 -lactamase. The non-
coding mutation (g4205a) is not included in our present study as this does not directly 
affect the chemical structure of the -lactamase. As discussed earlier, the substrate 
binding process is most likely the rate limiting step, and therefore we have estimated the 
change in binding affinity for cefotaxime upon these four single mutants relative to the 
wild type affinity and compared this to the experimental activity. We have observed 
excellent agreement between change in binding affinities of mutant enzymes and its 
experimentally reported minimum inhibitory concentrations[29] (MICs). The MIC and 
catalytic activity has been shown to be almost linearly correlated for bacterial 
resistance[160]. We have further analyzed the structural changes upon mutations and 
observed that the substantial increase in catalytic activity for the G238S and E104K 
mutant enzymes is correlated with significant restructuring at active site, which is 
consistent with the previous experimental evidence regarding the G238S mutation[161-
163].  The present study provides a molecular level insight into the effect of the four drug 
resistance mutations on the cefotaximase activity of -lactamase, which is not only 
helpful in designing new class of antibiotics but also provides molecular level insight into 
the first step of the evolutionary trajectory through which bacteria become drug resistant. 
The findings of present work also provide a firm basis for the future molecular level 
study of the complete mutational trajectory for the evolution of TEM -lactamase and 





 To assess the effect of four mutations (G238S, E104K, A42G and M182T) on the 
binding affinity of TEM -lactamase for cefotaxime, we simulated modeled mutant 
enzymes as well as the wild type enzyme bound to cefotaxime. As there is no crystal 
structure at present for cefotaxime bound TEM -lactamase, cefotaxime was first docked 
into the binding pocket of the wild type enzyme structure. In the next step of our study, 
mutant enzymes bound to cefotaxime were generated by modeling the mutations in the 
wild type structure. Molecular dynamics simulations and MM-PBSA free energy 
calculations were performed in subsequent steps. The details of the methodology used in 
the present study are given below. 
 
1. Docking of Cefotaxime into binding pocket: 
 
Cefotaxime was docked into the crystal structure of TEM-1 (wild type) -lactamase 
(PDB ID: 1BTL[164]) using Autodock4[165]. The amino acid sequence of this crystal 
structure is consistent with the definition of wild type enzyme used in the experimental 
study[29]. This structure has also been used in several previous theoretical studies with 
benzylpenicillin and cephalosporin[166, 167]. Also, Autodock has been successfully used 
to determine the enzyme bound structures of benzyl penicillin and cephalosporin, which 
are in close structural resemblance with cefotaxime[166, 167]. The C2-down conformer 
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of dihydrothiazine ring of cefotaxime was used for docking as this conformer has been 
suggested to be more stable and abundant in the structurally similar molecule 
cephalosporin in the enzyme bound state[167]. This conformation was held fixed during 
the docking.  
Prior to the docking calculations, the active site region was defined as in previous 
studies[166, 167]. In order to cover the entire region of the binding site, a sufficiently 
large grid around the catalytic site of the enzyme was used within Autodock4.  The 
conformational searches were performed using a genetic algorithm (GA), and a 
maximum number of energy evaluations per GA run were set to 25000000. The rest of 
the parameters were set to the default values within Autodock4.   
 
2. Ligand parameterization. 
 
The parameterization of cefotaxime was performed on its docked conformation 
(without the receptor). The cefotaxime was assigned force field parameters from the 
general AMBER force field[168] (GAFF) for small molecules, using the 
ANTECHAMBER package[169]. The partial atomic charges on the cefotaxime were 
derived using R.E.D tools[170]. The cefotaxime was first minimized in Gaussian03[171] 
using HF/6-31G* basic sets. In next step, the partial atomic charges were derived using a 





3. Modeling the mutations: 
 
The mutations in TEM-1 -lactamase enzyme were made using the tools of 
MODELLER, as developed by Feyfant et. al[173]. This method uses a combination of a 
knowledge based potential and a simulated annealing protocol to build side chain 
conformations of mutant residues. The details of this protocol can be found in the original 
publication[173]. Since none of the mutant positions were found to make any significant 
contact with cefotaxime in the wild-type modeled complex, the presence of the ligand in 
the binding pocket was not a requirement for the accurate modeling of side chain 
conformations of mutant amino acids. Therefore, the mutations were built within the 
original crystal structure of TEM-1 -lactamase (PDB ID: 1BTL). 
 
4. System Preparation and Molecular Dynamics simulation protocol: 
 
In order to accurately model the Michaelis complex, a water molecule was placed 
between residues Ser70 and Glu166 of enzymes taking structural information from 
previous studies[152, 167]. This water molecule has a key role to play during 
catalysis[152], however, this water has not been shown to make any significant 
contribution towards the ligand specificity[166, 167]. All enzyme ligand complexes were 
solvated in an octahedral simulation box of TIP3P water molecules, using tleap within 
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Amber10[174, 175]. The Amber ff99SB[176] force field was used to describe the protein 
part of the enzyme-cefotaxime complex. The minimum distance between any of the 
atoms of the solvated complex and the box boundary was maintained to at least 10 Å. 
The systems (all enzyme-ligand complexes as well as unbound enzymes) were 
neutralized by the addition of potassium ions.  
During all energy minimization and molecular dynamics simulations, the electrostatic 
interactions between atoms were treated using a particle mesh Ewald (PME) 
method[177], with a B-spline order of 4 and direct space cutoff of 10 Å. The Lennard-
Jones interactions were computed within a cutoff of 10 Å. All the bonds involving the 
hydrogen were constrained using SHAKE[178] in Amber10.  
In the next step, minimization of the systems was carried out using SANDER module 
of the Amber10 package. In the first part of minimization, the solute atoms were held 
harmonically restrained (with a very high force constant of 500 kcal/mol/Å2) and the 
systems were minimized for 1000 steps using a steepest descent algorithm and 1000 steps 
using a conjugate gradient algorithm. In the next part of minimization, the force constant 
for the positional restraint on the solute atoms was reduced to 50 kcal/mol/Å2 and the 
systems were further minimized for 1000 steps using the steepest descent algorithm.  
Once the systems were relaxed, the gradual heating of the systems was performed 
within the SANDER module. The systems were gradually heated from 0 K to 300 K 
during 100 ps of simulation, with a 1 fs time step for integration. The solute atoms were 
restrained with a force constant of 5 kcal/mol/Å2, in order to avoid any significant 
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structural deformation during the heating process. After heating, the density equilibration 
simulation was performed. The molecular dynamics simulation of the systems were 
performed in constant pressure and temperature (NPT) ensemble for 500 ps, with 
pressure relaxation time of 1.0 ps and 2 fs time step for integration. The solute atoms 
were restrained with a relatively weak force constant of 2 kcal/mol/Å2 during NPT 
simulation. The temperature was maintained to an average value of 300K using Langevin 
dynamics, with collision frequency of 2 ps-1. After achieving a density equilibration 
corresponding to 1atm pressure, all the restraints on the systems were removed and 
further simulations were performed in constant volume ensemble (NVT) within the 
PMEMD module of Amber10, with a 2 fs time step of integration. Total 30 ns of 
equilibration and 10 ns of the production simulations were performed for the free-energy 
estimation and structural analysis. 
 
5. MM-GBSA binding affinity calculation: 
 
The binding affinities of cefotaxime to the wild type as well as mutant enzymes were 
estimated using an MM-GBSA protocol[179-181]. The MM-GBSA protocol is not only 
computationally efficient in comparison to the traditionally used MM-PBSA and other 
free energy estimation techniques, but also has been shown to be in excellent qualitative 
agreement with MM-PBSA and experiment[37].  
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According to the MM-GBSA protocol, the free energy of binding can be estimated 
using the following formulation.  
 
   GMM-GBSA = GMM + Gsol –TS 
 
   Gbind = GMM-GBSAcomplex + GMM-GBSAreceptor - GMM-GBSAligand 
 
   Gbind = GMM + Gsol - TS 
 
Where, the Gbind is the binding free energy, GMM is the molecular mechanics free 
energy contribution to the binding free energy (which is contribution from the gas phase 
energies of isolated molecules), Gsol is the solvation contribution to the binding free 
energy and -TS is the contribution from the conformational entropy change. In previous 
studies, it has been suggested that the conformational entropy change upon single point 
mutation is negligible and can safely be ignored[182, 183]. And therefore, the 
conformational entropy change upon mutation has not been included in the present study. 
The -loop (residues 161-179) of ligand free  -lactamase has long time scale 
motion[184], which cannot be properly sampled on nanosecond time scale simulation. 
And therefore, in order to avoid the error caused by the insufficient sampling of the -
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loop, the MM-GBSA energies of complex and receptor was estimated from same 
trajectory (see the discussion section for more details). In order to account for the internal 
energy change of cefotaxime upon binding, a trajectory from separate simulation was 
used for the ligand MM-GBSA free energy calculation. 
The molecular mechanics contribution to the binding affinity (GMM) can be written 
as the contribution from Columbic (Gelec) interactions, van der Waals (GvdW) 
interactions and from internal energy change (Ginte). The internal energy term here 
include bond, angle and dihedral energies of a molecule.  
 
GMM = Gelec + GvdW + Ginte 
 
The Columbic, van der Waals and internal energy contributions to the binding affinity 
were estimated using exactly the same parameters that have been used for energy 
minimization and molecular dynamics simulations. While calculating the interaction 
energies, no cutoff was used for non-bonded interactions.  
The solvation free energy contribution to the binding affinity can be written as sum of 
polar (Gsolpol) and non-polar (Gsolnon-pol) contributions.  
     




The polar contribution to the solvation free energy was estimated using generalized Born 
(GB) method in Amber10. The non-polar contribution to the solvation free energy was 
calculated using solvent accessible surface area (SASA) method as 
   
Gsolnonpol =  *  SASA 
 
The value of 0.0072 kcal/mol/Å2 was used for surface tension coefficient . The SASA 
was determined with the MOLSURF method, as implemented in Amber10. 
 
6. Per-Residue decomposition: 
 
The free energy estimated using an MM-GBSA method can be efficiently 
decomposed into its per-residue contributors, which can provide further insight into a 
binding mechanism. The per-residue decomposition of the MM-GBSA binding affinity 
has been successfully used in addressing several questions, including the prediction of 
some drug resistant mutations in HIV-1 protease[128].  
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The details of the per-residue decomposition of MM-GBSA binding free energy in 
AMBER can be found elsewhere[185]. In brief, the contribution of jth residue to the 
binding free energy from ith snapshot of species x can be written as: 
 
 
The contribution of residue j electrostatic (Columbic + polar solvation) free energy can 
be obtained by: 
 
 
    
Where, the first term designate the electrostatic contribution to the solvation free 
energy calculated using GB. The second term stands for the Columbic interaction energy. 
The w is the dielectric constant, qk and ql are the partial charges on the atoms k and l, and 
rkl is the distance between respective atoms. The internal energies (bond, angle, and 





































1. Docked conformation of cefotaxime: 
 
Cefotaxime was docked into the binding pocket of the wild-type -lactamase. The 
structure with the highest population, which also has one of the lowest energies, was 
selected as the representative of the -lactamase bound structure of cefotaxime (figure 
6.2). This low energy solution has the reactive -lactam ring of cefotaxime in the correct 
proximity to catalytic residue Ser70. This conformation also makes several contacts (with 
residues Ser70, Ser130, Ala237, Arg244, Asn132, Lys234, Ser235), which have been 
recognized as the key contact with its structurally similar molecules benzylpenicillin and 
cephalosporin in previous studies[166, 167]. A majority of these contacts were found to 































Figure 6.2: Results of the automated docking calculation. In this graph, each bar represents the 








Table 6.1: The key hydrogen bonds as observed in docking calculations. The distances 
between heavy atoms are reported.   
 














1. Binding free energy calculations: 
 
The effect of four mutations (A42G, E104K, M182T, and G238S) in TEM-1 -
lactamase on the binding affinity for cefotaxime was examined. The MM-GBSA binding 
affinities were estimated by analyzing 1000 snapshots, taken during the last 10 ns of the 
production simulation. The MM-GBSA binding affinities of wild type and four mutants 
for cefotaxime are shown in the table 6.2. Out of the four mutants studied, the highest 
binding affinity for cefotaxime was observed for the G238S mutation of TEM-1 beta 
lactamase. The G238S mutation is also the one that has been shown to exhibit the 
maximum MIC (1.410 µg/ml) of cefotaxime[29].  As it has been mentioned earlier, the 
MIC and catalytic efficiency for bacterial resistance are lineally correlated[160]. 
Therefore, the G238S mutation contributes the most towards improving the catalytic 
efficiency of the -lactamase by increasing its binding affinity toward cefotaxime. The 
E104K mutation ranks second in increasing the binding affinity of the enzyme for 
cefotaxime. The MIC of cefotaxime for E104K mutant enzyme was determined to be 
0.132 µg/ml[29], which also ranks second after the G238S mutant enzyme. The M182T 
mutation which has been found to decrease the MIC compared to the TEM-1 -
lactamase, was estimated to lower the binding affinity of the enzyme toward cefotaxime. 
The binding affinity of the A42G mutant enzyme, which has an MIC equal to wild type, 
was found to be very close to that of the wild type structure. Hence, the binding free 
energy data shown in table 6.2 suggest that cefotaximase activity of TEM-1 beta 
lactamase evolves by increasing its binding affinity (and therefore specificity) for 
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cefotaxime, which is consistent with previous experimental studies and proposals[161-
163].    
More insight into the binding mechanism can be obtained by looking into the 
different components of the MM-GBSA binding affinity. As shown in table 6.2, the 
substantial favorable change for cefotaxime binding affinity in the case of the G238S 
mutant enzyme compared to the wild type enzyme is primarily driven by the van der 
Waals energy term. This indicates the better accommodation of cefotaxime into the 
binding pocket of the -lactamase upon G238S mutation. The E10K mutant enzyme also 
increases its binding affinity for cefotaxime compared to the wild type through the van 
der Waals component, and appears to follow a mechanism similar to the G238S mutant 
enzyme for increasing its activity. In the case of the A42G and M182T mutant enzymes, 
the favorable van der Waals energy term is either compensated (for A42G) or overcome 





   Table 6.2:  Binding affinity data for TEM-1 -lactamase and its mutants with cefotaximea.  
 Gint GCoul  GvdW  Gsol  Gelec Gbind  GvdW Gelec Gbind  MIC[29
] 
(µg/ml) 
WT  0.39(0.25) -30.85(0.32) -32.34(0.17) 30.40(0.26) 5.09(0.15) -32.41(0.24) 0 0 0 0.088 
G238S  2.47(0.24) -37.27(0.31) -46.5(0.15) 39.61(0.25) 8.65(0.15) -41.67 (0.24) -14.16 3.56 -9.26 1.410 
E104K  1.59(0.24) -81.78(0.49) -39.84(0.17) 83.82(0.41) 7.84(0.19) -36.19 (0.27) -7.50 2.75 -3.78 0.132 
A42G  3.48(0.25) -15.29(0.31) -42.77(0.16) 21.43(0.24) 11.77(0.16) -33.16 (0.24) -10.43 6.68 -0.75 0.088 
M182T 0.55(0.24) 12.53(0.38) -41.55(0.17) 1.93(0.32) 20.26(0.14) -26.54 (0.23) -9.21 15.17 5.87 0.063 
aBinding affinities are in kcal/mol; Gelec = GCoul +Gpol-sol; The standard errors associated with the averages are given next 
to the values. 
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2. Structural Properties as observed during MD simulations: 
 
(i) Root Mean Square Deviation (RMSD): 
 
In order to gain insight into the effect of mutations on the structural properties of 
cefotaxime bound TEM -lactamase, we first monitored the root mean square deviation 
(RMSD) parameter. The average structures of the cefotaxime bound mutant enzymes 
from the production run (last 10 ns) were compared to that of wild type average structure. 
The average structures of the mutant enzymes were superimposed on the average 
structure of wild type enzyme using the coordinates of the main chain atoms (N, CA, and 
C atoms according to PDB[34] nomenclature), and the RMSD of the overall structure as 
well as of the structural units and of the individual residues were calculated. For 
convenience, the region between residues 86 and 118 was named as AS1 (active site 
region 1). Similarly, the regions from residues 213-229 and from residues 267 to 271 





Table 6.3:  Summary of the RMS Deviations for different domains of the cefotaxime 
bound enzymes. 
 G238S E104K A42G M182T 
Total 0.84 0.70 0.60 0.63 
-loop (161-179) 1.27 0.90 0.97 1.08 
AS1 (86-118) 1.11 1.07 0.86 0.75 
AS2 (213-229) 1.38 1.01 0.93 1.06 
AS3 (267-271) 1.72 1.04 0.66 0.50 
AS 1.26 1.01 0.90 0.90 






Out of the four mutant structures, the G238S structure was observed to exhibit the 
highest structural deviation from the wild type. The overall structural deviation (RMSD= 
0.84 Å) as well as the RMSD for the active site region (RMSD = 1.26 Å) for G238S was 
found highest among the four mutants (table 6.3). The structural deviation in different 
parts of the enzyme, as well as in the active site region of the E104K mutant enzyme was 
observed to be second highest after G238S (table 6.3). The -loop, which is a relatively 
flexible part of the enzyme, shows the largest structural deviation upon mutation 
compared to other regions.  
In order to analyze the structural deviation in more detail, we have calculated the 
RMSD for the every residue of the mutant enzyme relative to the wild type. As shown in 
figure 6.3, three distinct regions in the G238S mutant enzyme (AS1, AS2, and AS3) apart 
from -loop show significant structural deviation upon mutation. These four regions of 
the enzyme contain most of the residues that define the binding pocket for cefotaxime.  
The E104K mutant enzyme, which has the second highest binding affinity after G238S 
mutant, has a significant RMSD in these four regions (figure 6.3), however, less in 
comparison to the G238S mutant. For the A42G and M182T mutant, the structural 
change is less significant compared to the G238S and E104K mutant enzymes, other than 
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Figure 6.3: The RMSD of the residues of the cefotaxime bound mutant enzymes compared to the 






(ii): Hydrogen Bonds between Lactamase and Cefotaxime: 
 
Hydrogen bonds have a critical role to play in stabilizing protein-ligand 
complexes and therefore contribute significantly to developing specificity for a substrate. 
The most significant hydrogen bonds between cefotaxime and enzyme structures were 
examined by analyzing 1000 snapshots taken during the 10 ns of the production 
simulation. The enzyme-substrate hydrogen bonds were characterized in terms of 




Table 6.4: Summary of the average distances between heavy atoms involved in important hydrogen bonding interactions 
between cefotaxime and enzymes. 
 
Hydrogen bond  TEM-1 G238S E104K A42G M182T 
CEF-O····H-N-ALA237 3.22±0.39 2.92±0.17 3.17±0.45 2.86±0.14 2.93±0.15 
CEF-O6····H-N1-ARG244 3.38±0.47 2.88±0.20 2.85±0.19 3.12±0.33 4.73±0.57 
CEF-O2····H-N-ASN132 6.16±1.14 3.17±0.31 3.03±0.30 2.91±0.17 3.09±0.31 
CEF-O5····H-N-LYS-234 5.96±0.68 4.31±0.27 4.13±0.34 4.25±0.28 4.83±0.28 
CEF-O5····H-O-SER-130 6.58±0.60 2.67±0.15 2.71±0.16 2.69±0.15 2.72±0.21 
CEF-O5····H-O-SER-235 2.65±0.14 3.13±0.31 2.85±0.21 3.01±0.27 5.22±0.44 
CEF-O6····H-O-SER-235 3.94±0.47 2.78±0.17 2.97±0.22 2.87±0.20 4.61±0.42 
CEF-O····H-O-SER-70 4.28±0.52 2.94±0.23 3.47±0.53 3.17±0.21 3.12±0.20 
CEF-N1-H····O=C-ALA-237 6.14±0.40 3.41±0.28 4.56±1.28 3.37±0.29 3.14±0.26 
CEF-N4-H····O=C-PRO-167 4.52±1.55 4.66±0.40 5.40±1.31 5.22±0.84 5.10±0.76 
                               All the distances are given in Å 
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 The distances given in table 6.4 generally indicate the restructuring of ligand in 
the binding pocket upon mutations. However, the changes in the pattern of hydrogen 
bonding with cefotaxime upon single point mutations were not found to be a major 
contributor to change in binding affinity (table 6.2). Only two interactions involving the 
carbonyl oxygen (O) of the ligand (with residues Ala237 and Ser70) are consistently 
present within all mutant and wild type structures. These interactions with the carbonyl 
oxygen of the ligand help to maintain the reactive center of the cefotaxime in the right 
orientation relative to the catalytic residues of the enzyme.  Since all parts of the ligand 
(-lactam ring and two side chains) can be seen to form hydrogen bonds, all three parts of 
the ligand are responsible for binding the substrate within the active site and contribute 
towards the specificity. The negatively charged carboxylate group of cefotaxime makes a 
number of H-bonds with residues Ser130, Ser235 and Arg244 in the carboxylate group 
accommodating pocket and therefore appears to be major contributor to the binding 
affinity (see the discussion section). All hydrogen bonding interactions (except CEF-N4-
H····O=C-PRO-167)  reported in current study have been found to be present during a 
molecular dynamics simulation of cephalothin (another cephalosporin -lactam 
antibiotic) bound to TEM-1 -lactamase[167]. The CEF-O5····H-N-LYS-234 hydrogen 
bond is particular to the E104K mutant and is not very significant in other structures. The 
residue ALA237, which is involved in the formation of the so called “oxyanion 
hole”[167], makes two significant interactions with the ligand. The first interaction is 
CEF-O····H-N-ALA237, which is very significant in all mutants as well as in the wild 
type structures. The second interaction involving ALA237 is CEF-N1H····O=C-ALA-
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237, which is very significant in all mutant structures, but appears to be less significant in 





None of the four mutant positions examined in this study are present within the 
binding region of cefotaxime, as observed in docking calculations. The G238 and E104 
are near the cefotaxime binding pocket, however, none of these residues nor were the 
mutant residues at these positions found to make any significant contact with docked 
structure of cefotaxime. The residues A42 and M182 are far from the binding pocket. It is 
therefore not very clear how these four mutations will affect the binding affinity with the 
substrate. At the same time, there is no crystal structure available for these mutants in 
cefotaxime bound conformation which could give insight into to its resistance 
mechanism.  
Since wild type -lactamase cannot properly accommodate the cefotaxime in its 
binding pocket, structural changes at active site upon mutation have been proposed as the 
possible mechanism for developing resistance [161-163]. The G238S mutation causes a 
maximum increase in catalytic efficiency compared to other three single point mutations, 
and therefore it has been center of attraction. Considering the physiological implications 
of the G238S mutation, an experimental study was performed to correctly identify the 
role of Ser[161]. In the experimental study, the hydroxyl group of Ser was not found to 
make any direct contribution towards the binding affinity for cefotaxime through 
hydrogen bonding, and therefore it was suggested the restructuring at the active site is the 
possible reason for the increase in the catalytic activity of -lactmase upon G238S 
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mutation[161]. However, it is not clear from the experiment that what type of structural 
changes take place upon this mutation. 
As shown is the figures 6.3 and figure 6.4, the active site restructuring is evident 
in G238S mutant enzymes, which is consistent with the experimental studies[161-163]. 
Most significant restructuring was found to takes place in -loop. As shown in figure 6.4, 
the -loop in G238S mutant enzyme is opening up and providing more space for the 
ligand to fit into the binding pocket. The significant structural change in other part of 
active site (AS1, AS2, and AS3) were also observed apart from structural changes in -
loop (figure 6.3 and 6.4), which aid into the ability of enzyme to bind better to 
cefotaxime. No hydrogen bonding interaction with hydroxyl group of Ser238 residue to 
any part of the cefotaxime was observed during the MD simulation. And therefore, the 
entire increase in binding affinity is coming from the active site restructuring caused by 
G238S mutation, which is in agreement with the previous experimental observation[161].    
The structural changes in the binding pocket of E104K mutant enzyme are also 
very significant. In the case of E104K mutation, the most significant structural changes 
were observed in AS1, AS2 and AS3 regions (figure 6.3 and 6.4), along with significant 
structural changes in -loop. As mentioned earlier, these structural changes in active site 
region appear to help in increasing the binding affinity of the E104K mutant enzyme for 
the cefotaxime.  The structural changes in active site region are less significant for the 
A42G and M182T mutants, which does not show increase in catalytic efficiency (figure 
6.3 and 6.4). The correlation between structural changes at active site and increase in 
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catalytic activity for cefotaxime indicate that the restructuring of active site is a general 









Figure 6.4: Active site region of the averaged structures of the mutant enzymes superimposed 





The C2 atom of the dihydrothiazine ring of cefotaxime can flip between up and 
down conformations with respect to the plane formed by C, S, and C3 atoms of the ring, 
and therefore the cefotaxime can adopt two distinct conformations based on the 
orientation of C2 atom. These conformations of cefotaxime are termed as C2-up and C2-
down conformations. Majority of the crystal structures of third generation cephalosporin 
-lactam antibiotics bound to -lactamase  have been reported to exhibit the C2-down 
conformation[167]. In a previous theoretical study, it has been suggested that C2-down 
conformation in cephalosporin is energetically favored[167].  It has also been suggested 
that the preference between C2-up and C2-down conformations is mainly governed by 
the conformational preferences of antibiotic side groups[167, 186].  
 In the present study, we have further rationalized the structural implications of the 
C2-down conformation. We have observed that in G238S mutant enzyme which has the 
highest activity against cefotaxime, the cefotaxime adopts C2-down conformation 98.6% 
time of total 10ns production run. For the M182T mutant enzyme, which has lowest 
activity among the mutant enzymes, the C2-up conformation was found to be populated 
during 100% time of the production simulation length. As shown in figure 6.5, in the case 
of C2-down conformation, the two side chain of cefotaxime adopts an extended 
conformation relative to the C2-up conformation. This can be thought as an indicative of 
the volume difference between active sites of these two mutant enzymes. The G238S 
mutant enzyme is providing an extended binding pocket compared to M182T mutated 
enzyme which help accommodating the cefotaxime better.  The population of C2-down 
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conformation for E104K, A42G and wild type structures were found to be 44.3%, 6.2% 









Figure 6.5: The superimposition of average ligand structures from G238S mutant enzyme 
simulation (blue) and M182T mutant enzyme simulation (green).  The ligand bound in G238S 
mutant enzyme’s pocket can be seen as adopting extended conformation compared to the ligand 
bound to M182T mutant enzyme.  
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As mentioned earlier regarding MM-GBSA, apart from being computationally 
efficient and reliable in predicting the relative binding affinities, the MM-GBSA binding 
affinity can be efficiently decomposed into per-residue contributions which can provide 
further insight into binding mechanism. In present study, we have decomposed the total 
binding affinity as well as van der Waals and electrostatic part of binding affinity into its 
per-residue contributions. 
For the wild type structure, the major contribution to the binding affinity comes from 
the residue R244 which accommodates the carboxylic goup attached to the 
dihydrothiazine ring of cefotaxime. The R244 contribute towards binding affinity 
primarily through the electrostatic component (figure 6.6). The S235 is the other residue 
which significantly contributes (~2 kcal/mol) towards binding affinity through 
electrostatic component. The residues S70, Y105, S130, N132, V216, G326, and A237 












































































Figure 6.6: The per-residue decomposition of the MM-GBSA binding free energy of wild-type 
enzyme for cefotaxime. The first graph represents the per-residue decomposition of the total 
binding free energy. The second graph represents per-residue decomposition of electrostatic 
component (Columbic and electrostatic solvation) of binding free energy and the third graph 
represents the per-residue decomposition of van der Waals component of binding free energy. 




We further analyzed the differential binding affinities [G(mutant) = G(mutant) -
G(wild-type) ] of mutant enzymes for cefotaxime compared to wild type enzyme.  The 
differential increase in binding affinity of G238S mutant enzyme mainly come from the 
residues Y105, N170, K234, A237 and S238 (figure 6.7). Out of these residues, the 
Y105, N170, A237 and S238 contribute towards differential stabilization through van der 
Waals interactions (figure 6.8). The residue K234 increases differential binding affinity 
through electrostatic term (figure 6.9). In the case of E104K mutant enzyme, residues 
K104, Y105, N170 and A237 contribute towards differential stabilization through van der 
Waals interactions (figure 6.8). In E104K mutant enzyme, the K234 contributes 
significantly through electrostatic interaction (figure 6.9). The R244 position in E104K 
mutant is less differentially destabilizing (3.64 kcal/mol) compared the G238S mutant 
enzyme (4.08 kcal/mol). The R244 position in A42G mutant enzyme contributes more 
towards differential destabilization (5.11 kcal/mol) compared to E104K and G238S 
mutant enzymes, but less compared to M182T mutant enzyme where it is highest with the 
value of 7.4 kcal/mol (figure 6.7). R244 also contributes in differential stabilization 
through van der Waals interactions for all the mutant enzymes (figure 6.8).  In the case of 
A42G mutant enzyme, the contributions to differential binding affinity though van der 
Waals interactions come from residues P167, N170, A237, and R244 (figure 6.8). The 
residues N132 and K234 contribute through electrostatic interactions for A42G mutated 
enzyme (figure 6.9). The residues of M182T mutant enzyme make several differential 
stabilizing and destabilizing contributions to binding affinity. The differentially 
stabilizing contributions from M69, S70, N132, P167, N170, K234 and A237 are 
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overcomed by differential destabilizing contributions from S130, V216, S235 and R244. 






















































































Figure 6.7: Per-residue decomposition of differential binding free energy of the mutant enzymes 
for cefotaxime, compared to the wild type binding free energy.  Per-residue contribution of ligand 























































Figure 6.8: Per-residue decomposition of differential van der Waals component of binding free 
energy of the mutant enzymes for cefotaxime, compared to the wild type affinity. Per-residue 



































































Figure 6.9: Per-residue decomposition of differential electrostatic component of binding free 
energy of the mutant enzymes for cefotaxime, compared to the wild type affinity. Per-residue 
contribution of ligand residue is not represented in the above graphs.     
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In order to catalytically hydrolyze the cefotaxime, the -lactamase evolves by 
expanding its pre-existing ability to catalytically hydrolyze the benzylpenicillin.  Since, 
the mutants G238S and E104K retain some activity against benzylpenicillin while 
gaining the activity against the cefotaxime[187], the first step of evolution can be looked 
as the process of increasing its functional promiscuity. According to one of the proposed 
mechanism of the structural change in protein while acquiring the promiscuity[188, 189], 
the protein becomes more flexible upon mutations and can shift between alternate 
conformations without any significant free energy change.  On the potential energy 
diagram (figure 6.10), we can think of two potential energy well for the alternate 
structures. The well A corresponds to the native conformation and B corresponds to the 
alternate conformation which is required for the new function. According to the 
mechanism of increase in flexibility[188, 189],  both conformations A and B become 
almost equal in energy with very low energy barrier between them(case I in figure 6.10), 
and therefore, there is no significant energetic penalty in conformational change. 
However, usually only one type of beta-lactam antibiotic is used in the treatment bacterial 
infection, and therefore bacteria has no advantage in evolving for promiscuity. Therefore, 
the observed promiscuity may be just a side effect. In this case, there is a possibility that 
the conformation B becomes more stable compared to the conformation A, as suggested 
in previous studies[188, 190, 191]. This can be represented as the case II and III in figure 
6.10 (G23S, E104K and M182T mutations have been shown to increase the fold stability 
of -lactamase[192, 193]).  This will result into pre-adopted the conformation of enzyme 
which can preferentially bind to the new ligand.  
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 In order to address these possibilities, we have analyzed the structural properties 
of the unbound wild type and mutant enzymes during molecular dynamics simulation 
(figure 6.11 and figure 6.12). In brief, we did not observe any considerable change in 
flexibility (as quantified by root mean fluctuation of CA atoms) within the binding region 
of the unbound mutant enzymes. However, for G238S we have observed considerable 
change in the structure of active site region during the course of the production 
simulation. Similarly for E104K, we observed significant structural change in AS1 
region. Since the time scale over which conformational transition between state A and B 
takes place, or the time scale of the conformational transition from state A to B is not 
known, our observation based on the ns time scale simulation is just an indicative of what 
is most likely and does not necessarily provide a conclusive evidence about the 
mechanism regarding structural change. In the case of ligand bound structures, these 
conformational changes are accelerated in molecular dynamics simulation by the 
presence of the ligand in the binding pocket of enzyme. One more thing should be 
noticed here that, in case of whatever mechanism among the above discussed possibilities 
is true, the free energy difference between bound and unbound conformer of enzyme will 
be very small. And therefore, our assumption that the change in internal energy of 
enzyme is negligible upon ligand binding (and therefore no separated unbound enzyme 









Figure 6.10: The figure depicts the potential energy profile of two conformation of an enzyme. The case I depicts evolution by increasing 


















































Figure 6.11: The root mean square deviation (RMSD) of the residues of the unbound mutant 








































Figure 6.12: The root mean square fluctuation (RMSF) for unbound mutant enzymes. The RMSF 





In the present work, we have been able to successfully separate the beneficial 
mutations (G238S and E104K) from non-beneficial mutations (A42G and M182T) at the 
first step of beta-lactamase evolution within a background of selective pressure. We have 
further identified the structural rearrangement within active site of enzyme upon mutation 
as the possible mechanism, which helps increasing its activity against cefotaxime. The 
active site rearrangement could be a general mechanism for increasing its activity against 
cefotaxime upon any combinations of above discussed single point mutations. The 
energetic calculations in combination of structural analyses presented in current 









SUPPLEMENTARY INFORMATION FOR CHAPTER ONE 
 
The following tables contain binding affinity data for all the native as well as distorted 
complexes used in the present study. The mean energies are in kcal/mol with a 
corresponding standard error in following column.  
 
Table AA.1: 1D7J.pdb 
 
Experimental binding affinity = -4.5 kcal/mol[194] 
 
RMSD (Å)  H SE -TS SE G SE 
       
Native 
Complex 
























-26.572411 0.062111 -12.1606 0.400221 -14.4118 0.405012 
0.727137 -29.104891 0.061766 -13.260568 0.318348 -15.844323 0.32428458 
0.94636 -23.226925 0.120222 -11.264962 0.295794 -11.961963 0.31929206 
0.995319 -24.137968 0.081314 -11.832568 0.254813 -12.3054 0.26747267 
1.00042 -28.074345 0.089772 -11.880897 0.393848 -16.193448 0.40394957 
1.01942 -22.712315 0.089827 -11.508942 0.255019 -11.203373 0.27037674 
1.03671 -28.120439 0.073803 -12.552111 0.411703 -15.568328 0.41826576 
1.10401 -28.239986 0.092998 -12.617528 0.3718 -15.622458 0.38325431 
175

1.14355 -30.775795 0.068723 -12.947574 0.303465 -17.828221 0.31114925 
1.2171 -23.800483 0.065934 -12.013633 0.291272 -11.78685 0.29864137 
1.29314 -23.622737 0.057321 -11.618821 0.257236 -12.003916 0.26354517 
1.31656 -22.686519 0.07942 -11.618179 0.271738 -11.06834 0.28310612 
1.35181 -30.483437 0.085305 -12.884116 0.312325 -17.599321 0.32376511 
1.35551 -23.431978 0.08279 -12.093503 0.342081 -11.338475 0.35195681 
1.39959 -20.678426 0.075693 -11.376432 0.353779 -9.301994 0.36178586 
1.60048 -27.449878 0.054735 -13.054362 0.308129 -14.395516 0.31295271 
1.60886 -20.094795 0.092221 -11.057536 0.291887 -9.037259 0.30610902 
1.89885 -24.909765 0.066091 -12.794185 0.332962 -12.11558 0.33945797 
2.02217 -26.007245 0.115615 -11.989032 0.325591 -14.018213 0.3455088 
2.14163 -24.85456 0.088305 -11.944766 0.294796 -12.909794 0.30773764 
2.305 -29.57228 0.086867 -12.806944 0.373642 -16.765336 0.38360686 
2.35808 -23.018212 0.090051 -11.740598 0.261643 -11.277614 0.27670606 
2.36868 -27.597348 0.059554 -13.287617 0.327524 -14.309731 0.33289435 
2.4252 -23.060419 0.074957 -11.809785 0.286352 -11.250634 0.29600003 
2.47242 -28.324937 0.091615 -12.385316 0.342926 -15.939621 0.35495288 
2.54512 -26.397179 0.081813 -13.581084 0.359306 -12.816095 0.3685026 
2.62652 -20.837078 0.085629 -11.369897 0.257218 -9.467181 0.27109671 
2.63266 -26.974243 0.063206 -12.330124 0.309606 -14.644119 0.31599189 
2.67609 -31.272223 0.075428 -13.083372 0.297734 -18.188851 0.3071399 
2.726 -23.625401 0.106544 -11.847169 0.302728 -11.778232 0.32092969 
2.76417 -26.055091 0.116597 -12.382952 0.338356 -13.672139 0.35788216 
2.8176 -28.618008 0.086693 -13.056646 0.316958 -15.561362 0.32860014 
2.88108 -23.91035 0.073399 -11.614882 0.307619 -12.295468 0.31625443 
2.92338 -23.691874 0.097685 -11.505514 0.347824 -12.18636 0.36128091 
2.92668 -23.817504 0.076087 -12.36109 0.330136 -11.456414 0.33879051 
2.93432 -28.502144 0.078271 -12.573225 0.338688 -15.928919 0.3476146 
3.02225 -22.09256 0.087504 -11.768281 0.282365 -10.324279 0.29561283 
3.16262 -24.372344 0.092438 -11.150671 0.32378 -13.221673 0.3367169 
3.18588 -19.769059 0.063637 -12.367648 0.29524 -7.401411 0.30202041 
3.25012 -30.140235 0.078332 -12.234614 0.321028 -17.905621 0.33044648 
3.59879 -27.142137 0.074163 -12.743566 0.354728 -14.398571 0.36239772 
3.60455 -20.389953 0.069278 -11.958911 0.307695 -8.431042 0.31539761 
3.62044 -25.040826 0.093989 -11.84351 0.260247 -13.197316 0.27669917 
3.62721 -20.505301 0.091731 -11.073104 0.302794 -9.432197 0.31638392 
3.78113 -31.258151 0.07534 -12.218651 0.348811 -19.0395 0.35685463 
3.85385 -37.983068 0.073363 -13.434247 0.340704 -24.548821 0.34851305 
3.92826 -23.388317 0.090614 -12.210879 0.33814 -11.177438 0.35007079 
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3.95457 -26.429204 0.106418 -11.693008 0.316483 -14.736196 0.33389561 
4.01356 -25.635705 0.124947 -11.762184 0.314326 -13.873521 0.3382493 
4.01398 -25.399803 0.041945 -12.499314 0.368569 -12.900489 0.3709481 
4.30388 -23.229647 0.106902 -12.091069 0.35482 -11.138578 0.37057424 
4.54993 -22.570574 0.094286 -11.50836 0.277111 -11.062214 0.29271207 
4.54993 -33.625002 0.068443 -12.403019 0.361479 -21.221983 0.3679015 
4.65814 -24.498047 0.088477 -11.030539 0.306459 -13.467508 0.31897539 
4.80338 -22.901148 0.07827 -12.204368 0.363264 -10.69678 0.37160049 
4.93072 -35.327257 0.080185 -12.752146 0.365555 -22.575111 0.37424603 
5.00367 -24.026303 0.072055 -12.054461 0.29344 -11.971842 0.30215717 
5.09211 -28.549311 0.064731 -12.586399 0.397159 -15.962912 0.40239952 
5.17215 -23.525299 0.098761 -11.957806 0.324861 -11.567493 0.33954146 
5.27617 -25.177852 0.132369 -11.707924 0.322689 -13.469928 0.34878323 
5.28545 -38.737094 0.079867 -12.883146 0.426942 -25.853948 0.43434803 
5.28545 -32.543533 0.056519 -14.652174 0.444235 -17.891359 0.44781596 
 
Table AA.2: 2IFB.pdb 
 
Experimental binding affinity = -11.10kcal/mol[195] 
RMSD (Å)  H SE -TS SE G SE 
       
Native 
Complex 
























-89.0827 0.124648 -22.0988 0.611515 -66.9839 0.62409 
1.63158 -87.403541 0.106609 -19.802318 0.636335 -67.601223 0.64520362 
1.68217 -84.040073 0.111055 -23.08527 0.691211 -60.954803 0.70007561 
177

1.70679 -90.970469 0.105573 -21.709466 0.593978 -69.261003 0.60328726 
1.73156 -93.299519 0.12027 -23.083204 0.632436 -70.216315 0.64377028 
1.74247 -89.380323 0.125565 -23.522834 0.684946 -65.857489 0.69636025 
1.75455 -81.586421 0.0832 -22.670964 0.766721 -58.915457 0.77122197 
1.79758 -96.454782 0.133763 -21.992056 0.591305 -74.462726 0.60624594 
1.8153 -93.393452 0.119714 -23.449942 0.662083 -69.94351 0.67281895 
1.9133 -99.22965 0.320935 -22.692002 0.562341 -76.537648 0.64747716 
1.94027 -92.597268 0.12793 -21.96739 0.626062 -70.629878 0.63899899 
1.96179 -84.076926 0.101184 -22.419776 0.618029 -61.65715 0.62625717 
1.9942 -73.541762 0.090855 -21.03236 0.652697 -52.509402 0.65899014 
2.02203 -100.816766 0.126299 -21.590436 0.653889 -79.22633 0.66597467 
2.03971 -68.723123 0.112619 -21.13106 0.593029 -47.592063 0.60362773 
2.06049 -85.714243 0.114675 -21.103861 0.680453 -64.610382 0.69004829 
2.09275 -96.32263 0.129707 -25.065814 0.675661 -71.256816 0.68799832 
2.11452 -106.690005 0.126044 -22.118222 0.612135 -84.571783 0.62497708 
2.17659 -80.009733 0.125102 -19.397465 0.681164 -60.612268 0.69255679 
2.19515 -94.841529 0.126398 -19.574188 0.589514 -75.267341 0.60291227 
2.21715 -105.187981 0.118536 -22.184662 0.699369 -83.003319 0.7093432 
2.21877 -90.397542 0.132171 -22.187276 0.595093 -68.210266 0.60959401 
2.26667 -107.189598 0.137167 -24.537826 0.721418 -82.651772 0.73434237 
2.2701 -85.459632 0.10038 -21.63543 0.694073 -63.824202 0.70129414 
2.3558 -91.746652 0.121801 -21.388704 0.707727 -70.357948 0.7181316 
2.36088 -86.45386 0.1269 -22.795318 0.576737 -63.658542 0.59053296 
2.51365 -103.358409 0.127842 -23.51055 0.598073 -79.847859 0.61158392 
2.54569 -80.40344 0.092602 -19.694432 0.632513 -60.709008 0.63925568 
2.65945 -99.36166 0.119888 -20.471614 0.652752 -78.890046 0.66367033 
2.6645 -55.014837 0.071759 -21.958306 0.623472 -33.056531 0.62758799 
2.89208 -96.312517 0.161559 -20.420263 0.638538 -75.892254 0.65865931 
3.01207 439.87679 0.43578 -27.41748 0.808431 467.29427 0.91840345 
3.10099 -52.771295 0.143781 -19.97204 0.553022 -32.799255 0.57140731 
3.26106 -95.904107 0.161661 -23.089934 0.646343 -72.814173 0.66625337 
3.28317 -105.132834 0.140313 -23.364504 0.615624 -81.76833 0.63141163 
3.53058 -92.251358 0.113434 -22.68901 0.622929 -69.562348 0.63317281 
3.59118 -81.792542 0.104355 -20.485326 0.656456 -61.307216 0.66469876 
3.62397 -94.40146 0.137312 -22.980728 0.688621 -71.420732 0.70217766 
3.71905 -93.27221 0.229647 -23.702602 0.634049 -69.569608 0.6743559 
3.79633 -99.541384 0.149661 -22.49114 0.605194 -77.050244 0.62342457 
3.91179 -95.643914 0.165691 -25.048784 0.701856 -70.59513 0.72114863 
3.94326 -93.254905 0.154406 -20.88737 0.724675 -72.367535 0.74094201 
178

3.95442 -95.814892 0.103392 -18.761516 0.702237 -77.053376 0.70980752 
4.05531 -76.701267 0.092901 -20.343028 0.570442 -56.358239 0.57795733 
4.28202 -89.560554 0.117131 -23.13717 0.693829 -66.423384 0.70364647 
4.45364 -101.297345 0.156083 -23.469002 0.661901 -77.828343 0.68005502 
4.48865 -90.205262 0.109447 -21.996486 0.594516 -68.208776 0.60450634 
4.65791 -99.775825 0.132961 -21.103592 0.659194 -78.672233 0.6724696 
5.02984 -148.777266 0.17957 -23.506338 0.756159 -125.27093 0.77718841 
5.03896 -100.867596 0.110917 -25.253204 0.695467 -75.614392 0.70425629 
5.10036 -100.40455 0.251971 -22.139368 0.686634 -78.265182 0.73140661 
5.27728 497.116381 0.452732 -27.647506 0.832169 524.763887 0.94734973 
5.3847 -124.639752 0.151218 -20.733484 0.649273 -103.90627 0.66665007 
 
 
Table AA.3: CYH.pdb 
 
Experimental binding affinity = na 
RMSD (Å)  H SE -TS SE G SE 
       
Native 
Complex 
























-72.229057 0.168798 -15.4262 0.406135 -56.8029 0.439816 
1.13178 -72.436587 0.166713 -14.570021 0.456958 -57.866566 0.48641941 
1.37547 -67.176187 0.22934 -15.440094 0.455184 -51.736093 0.50969531 
1.41169 -69.543555 0.128052 -15.90176 0.384162 -53.641795 0.40494167 
1.46908 -67.824121 0.156883 -15.603714 0.391649 -52.220407 0.4219019 
179

1.51354 -68.755813 0.144426 -15.409556 0.395624 -53.346257 0.42116175 
1.53332 -63.849118 0.15772 -15.60654 0.374646 -48.242578 0.40649136 
1.54545 -64.498715 0.281122 -14.871003 0.430185 -49.627712 0.51389562 
1.54928 -70.947836 0.201498 -14.997989 0.403681 -55.949847 0.45117601 
1.55185 -68.791695 0.13362 -16.442832 0.370586 -52.348863 0.39393945 
1.59341 -66.509285 0.279801 -14.911707 0.424803 -51.597578 0.508671 
1.6167 -73.753803 0.15531 -16.300714 0.451978 -57.453089 0.47791768 
1.63438 -64.560639 0.158279 -15.748215 0.427887 -48.812424 0.45622311 
1.74182 -57.694064 0.129458 -15.909445 0.388433 -41.784619 0.40943811 
1.78044 -66.024259 0.205231 -13.236777 0.530053 -52.787482 0.5683977 
1.82653 -56.122109 0.1812 -13.662595 0.411374 -42.459514 0.44951308 
1.84325 -62.845369 0.167325 -14.4913 0.354704 -48.354069 0.39218947 
2.18595 -51.958679 0.268069 -14.706677 0.415701 -37.252002 0.49463958 
2.19079 -63.362739 0.136345 -15.156098 0.377844 -48.206641 0.40169148 
2.20065 -67.860382 0.191501 -15.069832 0.396147 -52.79055 0.44000577 
2.23812 -57.067616 0.125088 -13.321246 0.356082 -43.74637 0.37741409 
2.27282 -44.866552 0.12635 -13.636352 0.367704 -31.2302 0.38880658 
2.30014 -62.794966 0.234494 -14.205994 0.425472 -48.588972 0.48581258 
2.34822 -60.436649 0.146103 -14.48874 0.394936 -45.947909 0.42109444 
2.49166 -75.28656 0.186323 -17.130778 0.442547 -58.155782 0.48017091 
2.56071 -73.569136 0.248487 -14.750524 0.430325 -58.818612 0.49691588 
2.78955 -66.230098 0.141338 -14.428212 0.513952 -51.801886 0.53303198 
2.83144 -54.846609 0.100728 -13.309275 0.333642 -41.537334 0.34851559 
2.88991 -55.142966 0.115375 -14.220224 0.418249 -40.922742 0.43387051 
2.89235 -61.814532 0.177124 -15.299197 0.435387 -46.515335 0.47003697 
2.94251 -69.093995 0.159412 -14.473964 0.420265 -54.620031 0.44948288 
3.16081 -69.335757 0.169076 -15.898354 0.436908 -53.437403 0.4684819 
3.16152 -90.671605 0.194524 -18.213178 0.450694 -72.458427 0.49088152 
3.19457 -58.469803 0.200234 -14.325384 0.409412 -44.144419 0.45575414 
3.2648 -78.672663 0.258812 -16.2513 0.470198 -62.421363 0.53672135 
3.26663 -52.546878 0.157117 -14.513088 0.407822 -38.03379 0.43704066 
3.29871 -64.436161 0.193021 -14.893625 0.448116 -49.542536 0.48791911 
3.38614 -52.816837 0.097635 -14.624124 0.384218 -38.192713 0.39642914 
3.4039 -79.807412 0.195569 -15.150851 0.52409 -64.656561 0.55939035 
3.43291 -62.895712 0.179222 -14.502203 0.431959 -48.393509 0.46766345 
3.45099 -59.898315 0.113628 -14.08567 0.451812 -45.812645 0.46588132 
3.45564 -59.342291 0.255626 -14.040714 0.430582 -45.301577 0.50074496 
3.54851 -76.932364 0.205727 -13.579596 0.329099 -63.352768 0.38811049 
3.58574 -65.95536 0.165283 -14.195246 0.357671 -51.760114 0.39401398 
180

3.74401 776.474389 0.606621 -22.196038 0.531384 798.670427 0.80644776 
3.74923 -51.601125 0.139221 -12.731389 0.388548 -38.869736 0.41273725 
3.78018 -60.890997 0.155957 -14.34745 0.438867 -46.543547 0.46575404 
3.87309 -60.909328 0.188306 -14.699614 0.438848 -46.209714 0.47754237 
3.91271 -58.266693 0.239126 -13.386887 0.415999 -44.879806 0.47982957 
3.9397 -58.599186 0.15196 -14.31241 0.456195 -44.286776 0.48083856 
3.96144 -61.664402 0.199895 -15.757938 0.412884 -45.906464 0.45872782 
4.00102 -70.132314 0.161315 -14.788016 0.493494 -55.344298 0.51919058 
4.01201 -72.569342 0.186445 -14.270854 0.467015 -58.298488 0.50285659 
4.07071 -55.831468 0.183432 -14.233333 0.421981 -41.598135 0.46012527 
4.11951 -61.900133 0.158146 -13.878261 0.420309 -48.021872 0.44907662 
4.13919 -64.89583 0.187843 -14.71405 0.399475 -50.18178 0.44143546 
4.22332 -64.09401 0.116148 -13.302229 0.45705 -50.791781 0.47157721 
4.23581 -72.310455 0.190888 -16.996134 0.490937 -55.314321 0.52674222 
4.32026 -57.37377 0.195317 -13.159721 0.369103 -44.214049 0.4175952 
4.32995 -65.970188 0.217471 -15.86731 0.399915 -50.102878 0.45522043 
4.49795 -64.158556 0.121912 -15.366929 0.446892 -48.791627 0.4632224 
4.52025 -62.490028 0.188912 -15.478686 0.385291 -47.011342 0.42911176 
4.5486 -59.649844 0.137253 -12.483058 0.373613 -47.166786 0.39802646 
4.55619 -79.588005 0.183701 -17.47261 0.406622 -62.115395 0.44619223 
4.63167 -46.803554 0.07824 -12.957751 0.34089 -33.845803 0.34975347 
4.72722 -62.210026 0.120516 -15.202684 0.504662 -47.007342 0.51885243 
5.08618 -46.676725 0.187619 -13.614219 0.403738 -33.062506 0.4452025 
5.1038 -63.35938 0.227101 -14.408036 0.472259 -48.951344 0.52402617 
5.2054 -70.418545 0.182135 -15.30067 0.484442 -55.117875 0.51754923 
5.45163 -52.505185 0.122802 -13.866607 0.384609 -38.638578 0.40373805 
5.49467 -74.758649 0.197295 -13.826075 0.443942 -60.932574 0.48580842 
5.71442 -70.399933 0.130263 -15.200013 0.421622 -55.19992 0.44128626 
5.72121 -56.413346 0.20399 -14.602263 0.458998 -41.811083 0.50228586 
 
Table AA.4: 1LKK.pdb 
 
Experimental binding affinity = -9.4 kcal/mol[196] 
RMSD (Å)  H SE -TS SE G SE 
       
Native 
Complex 
-408.031634 0.468764 -31.850002 0.783489 -376.181632 0.91301407 
Native 
Complex 























-424.532 0.398933 -30.3466 0.72882 -394.186 0.762562 
1.90092 -434.634573 0.386899 -30.5544 0.715971 -404.080173 0.81382142 
1.97673 -401.330277 0.409102 -33.15177 0.73248 -368.178507 0.83898236 
1.99723 -330.40225 0.345046 -31.411662 0.716073 -298.990588 0.79486935 
2.04713 -312.299569 0.492667 -29.374196 0.684752 -282.925373 0.84356747 
2.0679 -329.166521 0.413248 -24.146466 0.618683 -305.020055 0.74400441 
2.08153 -397.471066 0.388194 -34.15737 0.742678 -363.313696 0.83801265 
2.12182 -441.920499 0.366296 -27.981068 0.678582 -413.939431 0.77113312 
2.14177 -365.41782 0.385113 -30.719786 0.749067 -334.698034 0.84226682 
2.17664 -349.017405 0.355098 -27.078888 0.615466 -321.938517 0.71055822 
2.17715 -307.235405 0.411072 -30.117632 0.674032 -277.117773 0.78949308 
2.18567 -412.574664 0.370309 -32.219768 0.72478 -380.354896 0.81390098 
2.19617 -452.921137 0.363477 -33.574978 0.770171 -419.346159 0.85163308 
2.2347 -400.197734 0.361969 -31.581118 0.758307 -368.616616 0.84026845 
2.24453 -389.461276 0.44494 -30.219538 0.699784 -359.241738 0.82925825 
2.26688 -356.207677 0.353324 -31.61191 0.756866 -324.595767 0.8352748 
2.26905 -271.085204 0.299422 -27.392306 0.667361 -243.692898 0.73145351 
2.34117 -379.833143 0.412058 -29.481956 0.708933 -350.351187 0.81998646 
2.34677 -432.544819 0.365294 -34.008196 0.758809 -398.536623 0.84215842 
2.37786 -418.453018 0.376857 -32.24299 0.709557 -386.210028 0.80342538 
2.49083 -374.18002 0.410646 -29.09577 0.719748 -345.08425 0.82865392 
2.53137 -331.627744 0.376264 -25.864672 0.597587 -305.763072 0.7061762 
2.98302 -351.042979 0.404677 -31.969986 0.745716 -319.072993 0.84844318 
3.02828 -394.142397 0.53847 -28.606912 0.718356 -365.535485 0.89776683 
3.0729 -308.079851 0.314229 -25.902436 0.629211 -282.177415 0.70331099 
3.14652 -292.323132 0.401918 -26.964874 0.651705 -265.358258 0.76567453 
3.36055 -202.940498 0.234737 -30.408366 0.690806 -172.532132 0.72959879 
3.38045 -377.441278 0.414656 -34.604154 0.813012 -342.837124 0.91264895 
182

3.53564 -263.39855 0.3273 -33.2576 0.770529 -230.14095 0.83716201 
3.63149 -338.956622 0.405783 -31.176214 0.741415 -307.780408 0.84519586 
3.69535 -327.502626 0.383693 -29.078828 0.697055 -298.423798 0.79567958 
3.69535 -330.258913 0.365048 -30.743366 0.779798 -299.515547 0.86101392 
3.72934 -289.638828 0.461626 -27.568898 0.662551 -262.06993 0.80750999 
3.80303 220.472275 0.51475 -34.863926 0.839889 255.336201 0.98507923 
3.81042 -286.153795 0.362164 -31.65688 0.720964 -254.496915 0.80681587 
3.81885 297.752297 0.438094 -29.413034 0.690592 327.165331 0.81782863 
4.09913 -337.648583 0.382286 -26.231868 0.66847 -311.416715 0.77006151 
4.30994 -265.378111 0.312514 -28.35867 0.669752 -237.019441 0.7390756 
4.41148 -234.031536 0.33355 -26.235268 0.607324 -207.796268 0.69289108 
4.47046 -319.466105 0.397137 -26.413628 0.685683 -293.052477 0.79238815 
4.50301 -183.239058 0.239057 -24.611356 0.642895 -158.627702 0.68590249 
4.51171 -359.857021 0.35493 -24.742554 0.616617 -335.114467 0.71147159 
4.59425 -356.811193 0.615526 -25.218368 0.734108 -331.592825 0.95801191 
4.61434 -133.009451 0.239126 -24.87123 0.610689 -108.138221 0.6558371 
4.78448 -288.010957 0.305855 -26.797566 0.627025 -261.213391 0.69764434 
4.82685 -298.304524 0.318057 -29.17018 0.732261 -269.134344 0.79835232 
4.83481 -283.978584 0.302669 -27.783036 0.6913 -256.195548 0.75465503 
4.84627 -247.791036 0.325918 -24.290476 0.626806 -223.50056 0.70647598 
4.91509 -231.522089 0.328104 -29.61275 0.710314 -201.909339 0.78243096 
5.03114 -317.891888 0.359395 -29.362038 0.665615 -288.52985 0.75644438 
5.12871 -248.314404 0.317311 -35.354424 0.813306 -212.95998 0.8730137 
5.24466 296.727617 0.912275 -38.836992 0.899993 335.564609 1.28149642 
5.31919 -305.910833 0.311547 -28.608418 0.681719 -277.302415 0.74953474 
5.35494 -288.353479 0.751766 -29.309116 0.697327 -259.044363 1.0253863 
5.44282 -234.776046 0.321624 -37.534808 0.928258 -197.241238 0.98239753 
5.73289 244.634397 0.500866 -33.903114 0.870036 278.537511 1.00390706 
6.22638 285.867282 0.5274 -27.680684 0.631615 313.547966 0.82285373 
 
 
Table AA.5: 1FKF.pdb 
 
Experimental binding affinity = -12.3 kcal/mol[197] 
RMSD (Å)  H SE -TS SE G SE 
       
Native 
Complex 


























-80.615289 0.122224 -26.0296 0.647446 -54.58568 0.6588817 
1.27036 -81.861514 0.102454 -23.579446 0.554917 -58.282068 0.56429575 
1.44909 -78.91196 0.103488 -25.718234 0.618171 -53.193726 0.6267736 
1.46068 -81.633371 0.134721 -25.394066 0.584217 -56.239305 0.59954921 
1.48019 -82.596128 0.129781 -25.497832 0.61714 -57.098296 0.63063848 
1.49149 -80.597293 0.100088 -25.327878 0.598393 -55.269415 0.60670569 
1.49149 -80.165938 0.101389 -25.070764 0.603344 -55.095174 0.61180365 
1.52494 -78.886774 0.114555 -24.423028 0.621912 -54.463746 0.6323744 
1.55528 -78.025116 0.117429 -25.293182 0.601295 -52.731934 0.61265426 
1.60316 -77.379329 0.119061 -25.112074 0.651744 -52.267255 0.66252982 
1.6833 -71.25694 0.134968 -24.735518 0.638892 -46.521422 0.65299261 
1.73739 -79.888923 0.1107 -25.799912 0.627612 -54.089011 0.63730002 
1.75264 -77.991309 0.107648 -25.756112 0.592129 -52.235197 0.60183457 
1.75589 -95.696365 0.167537 -24.224884 0.666951 -71.471481 0.68767164 
1.76704 -74.759709 0.105003 -23.044406 0.595143 -51.715303 0.60433502 
1.78088 -85.307949 0.124506 -24.881022 0.631261 -60.426927 0.64342225 
1.79503 -66.501126 0.114736 -24.251572 0.548968 -42.249554 0.56082993 
1.80701 -82.517665 0.21449 -24.364348 0.604879 -58.153317 0.64178233 
1.81334 -83.72354 0.110804 -26.370124 0.61316 -57.353416 0.62309125 
1.85701 -65.881828 0.09949 -23.374782 0.521838 -42.507046 0.53123738 
1.87989 -57.03092 0.123168 -22.569508 0.565494 -34.461412 0.57875195 
1.88541 -72.722242 0.141328 -24.272778 0.593105 -48.449464 0.60971071 
1.89224 -74.240793 0.126636 -27.7375 0.675852 -46.503293 0.6876137 
1.89458 -53.985551 0.092278 -20.067932 0.463233 -33.917619 0.47233467 
1.89578 -90.686041 0.137527 -27.433006 0.693599 -63.253035 0.70710201 
1.93298 -77.24912 0.115568 -25.971982 0.633303 -51.277138 0.64376133 
184

1.93887 -81.493451 0.109929 -23.218954 0.617758 -58.274497 0.62746261 
1.96531 -86.354952 0.121288 -25.895418 0.650466 -60.459534 0.66167726 
1.96876 -80.39885 0.114027 -25.3684 0.605344 -55.03045 0.61598987 
2.00267 -57.364231 0.116159 -17.573766 0.543955 -39.790465 0.55621934 
2.00629 -70.693377 0.167243 -23.96641 0.581723 -46.726967 0.6052866 
2.04332 -54.769576 0.087087 -20.296586 0.486694 -34.47299 0.4944241 
2.04332 -54.769576 0.087087 -20.296586 0.486694 -34.47299 0.4944241 
2.10115 -65.297386 0.100136 -22.588142 0.574894 -42.709244 0.58354977 
2.11561 -78.407442 0.117777 -24.933494 0.602724 -53.473948 0.61412347 
2.21592 -73.704709 0.108319 -23.80473 0.575253 -49.899979 0.5853623 
2.27754 -65.14944 0.126586 -24.946286 0.60457 -40.203154 0.61768026 
2.41055 -59.151986 0.084341 -22.394864 0.509047 -36.757122 0.51598668 
2.46638 -69.321604 0.099528 -23.109054 0.604994 -46.21255 0.61312606 
2.49382 -73.418612 0.108266 -23.375706 0.590613 -50.042906 0.6004542 
2.56296 -67.177434 0.104443 -23.802268 0.656956 -43.375166 0.66520638 
2.62764 435.728063 0.406923 -32.23058 0.751181 467.958643 0.85431799 
2.63338 -92.216578 0.13104 -25.40859 0.650292 -66.807988 0.66336353 
2.63448 -75.297402 0.147854 -23.616038 0.64098 -51.681364 0.65781165 
2.67578 -82.153985 0.107841 -24.14492 0.615941 -58.009065 0.62531032 
2.75532 434.041458 0.419681 -30.861666 0.778313 464.903124 0.88425294 
2.86214 -59.797513 0.110001 -20.842808 0.515015 -38.954705 0.52663144 
2.99392 -59.129056 0.083655 -24.267662 0.576713 -34.861394 0.5827487 
3.14454 426.583489 0.453695 -28.384916 0.730227 454.968405 0.85969217 
3.39517 383.135297 0.406718 -33.931028 0.832852 417.066325 0.92685597 
3.51823 -74.882738 0.144277 -22.21655 0.627252 -52.666188 0.64363105 
3.57472 395.047766 0.395676 -32.65872 0.723874 427.706486 0.8249564 
3.587 -79.937802 0.123294 -26.191564 0.66064 -53.746238 0.67204659 
3.62175 -89.027667 0.108159 -24.84515 0.713023 -64.182517 0.72117971 
3.85991 370.040064 0.422476 -29.869258 0.727936 399.909322 0.84165123 
4.0147 -70.932334 0.13602 -24.392372 0.60178 -46.539962 0.61696078 
4.1087 -82.386442 0.173786 -25.90425 0.655313 -56.482192 0.67796512 
4.1087 -82.386442 0.173786 -25.90425 0.655313 -56.482192 0.67796512 
4.15034 629.63333 0.524061 -31.319138 0.746604 660.952468 0.91217184 
4.25168 -63.716139 0.116735 -23.770586 0.539756 -39.945553 0.55223509 
4.3843 -78.209085 0.096006 -23.241962 0.649495 -54.967123 0.65655229 
4.39121 468.043829 0.453879 -29.644598 0.791807 497.688427 0.91266887 
4.41258 -97.255179 0.103283 -22.967212 0.672684 -74.287967 0.68056678 
4.61119 -63.798162 0.107218 -23.902466 0.590527 -39.895696 0.6001815 
4.62147 -68.397403 0.189806 -24.13882 0.699383 -44.258583 0.72468124 
185

4.62147 -68.397403 0.189806 -24.13882 0.699383 -44.258583 0.72468124 
4.62817 -69.029882 0.125454 -23.006796 0.588071 -46.023086 0.60130376 
4.70342 -64.310173 0.14207 -22.670128 0.59182 -41.640045 0.60863355 
4.80914 -77.195855 0.132886 -22.162246 0.596642 -55.033609 0.61126129 
4.99681 368.809352 0.412561 -31.353824 0.760482 400.163176 0.86518174 
5.00252 1089.811159 0.760568 -49.712238 1.155736 1139.5234 1.38354233 
5.02869 -62.114134 0.119157 -21.63399 0.495629 -40.480144 0.50975141 
5.04295 -73.408575 0.111447 -23.418662 0.547985 -49.989913 0.559203 
5.17912 -55.57466 0.104344 -20.872376 0.598304 -34.702284 0.60733463 
5.2297 -91.663816 0.167282 -26.935794 0.76482 -64.728022 0.78290031 
5.2473 368.153332 0.402923 -31.433196 0.79083 399.586528 0.8875579 
5.2626 -79.432059 0.191165 -23.564556 0.629757 -55.867503 0.65813216 
5.39045 -71.399275 0.125067 -21.13133 0.564297 -50.267945 0.57799036 
6.76027 -66.521227 0.206533 -22.259888 0.633382 -44.261339 0.66620465 
 
 
Calculated percent change in binding affinities: 
 
The following table contains the percent change in binding affinity for each protein-
ligand complexes and averaged over all complexes, within the respective RMSD blocks. 
The standard deviation is given in following column. 
Table 6. Percent change in binding affinity within respective RMSD block. 
1D7J   
RMSD (Å) %|G| SD 
<2 27.9944399 22.1806389 
>2 & <3 29.1573733 19.7072639 
>3 & <4 39.3971762 37.0560615 
>4 43.7803131 45.4465559 
Native 0 0 
   
2IFB   
RMSD (Å) %|G| SD 
<2 11.2745095 7.23872832 
>2 & <3 19.9711787 13.8033657 
>3 & <4 20.0172674 12.1059581 
186

>4 33.4168703 31.826922 
Native 0 0 
   
5CYH   
RMSD (Å) %|G| SD 
<2 14.0266604 7.66733623 
>2 & <3 20.7291937 13.2280315 
>3 & <4 20.871563 9.22298102 
>4 18.5894724 12.2604389 
Native 0 0 
   
1LKK   
RMSD (Å) %|G| SD 
<2 10.0211086 9.4687308 
>2 & <3 12.3483163 9.23509458 
>3 & <4 25.546895 12.5156185 
>4 34.579635 15.7516471 
Native 0 0 
   
1FKF   
RMSD (Å) %|G| SD 
<2 10.5888365 10.8771551 
>2 & <3 21.7787977 11.8545577 
>3 & <4 8.10694889 6.06447885 
>4 16.7695947 11.8734506 
Native 0 0 




RMSD (Å) %|G| SD 
<2 14.78111 7.54470507 
>2 & <3 20.79697 5.97759576 
>3 & <4 22.78797 11.2955653 
>4 29.42718 11.4689605 
Native 0 0 






SUPPLEMENTARY INFORMATION FOR CHAPTER TWO 
Table AB.1: The binding affinities of all the mutants and wild type structures towards 
the MC/CA substrate. The mean energies are reported in kcal/mole with standard error in 
the following column.  
 
Mutants H SE -TS SE GS SE 
i13a -61.4247 0.084285 -33.8248 1.159287 -27.5999 1.162347 
i13l -64.9968 0.092243 -34.2049 1.044125 -30.792 1.048192 
g17e -62.5295 0.08218 -32.2729 0.986579 -30.2567 0.989996 
v32i -65.3338 0.098566 -32.0303 0.937378 -33.3036 0.942546 
m36v -61.6208 0.093028 -33.9474 0.89588 -27.6735 0.900697 
m36i -63.5214 0.090369 -37.9317 1.111437 -25.5897 1.115105 
m36a -61.7167 0.090469 -34.4921 0.98662 -27.2246 0.990759 
n37s -61.8055 0.083012 -32.3233 1.045469 -29.4822 1.048759 
n37d -65.9411 0.092432 -38.4088 1.102619 -27.5323 1.106486 
n37q -61.3851 0.091404 -33.0841 1.087259 -28.3011 1.091094 
g40e -61.5837 0.094547 -33.0955 1.088237 -28.4882 1.092336 
k43r -64.6444 0.090866 -34.8902 1.098932 -29.7542 1.102682 
m46v -62.0327 0.090468 -35.6025 1.017937 -26.4302 1.021949 
m46t -64.4673 0.099904 -34.1156 1.018683 -30.3517 1.02357 
g48e -66.629 0.123129 -39.9954 1.142817 -26.6336 1.149431 
g48v -69.6779 0.102921 -35.6938 1.032483 -33.9841 1.0376 
l63p -63.163 0.094604 -34.6731 0.906709 -28.49 0.911631 
188

l63v -61.7616 0.103422 -35.9113 1.02891 -25.8503 1.034095 
l63k -68.1291 0.087068 -40.4848 1.037233 -27.6443 1.040881 
l63g -66.429 0.084319 -35.3906 1.009001 -31.0384 1.012518 
l63a -66.4265 0.095532 -37.5901 1.199584 -28.8365 1.203382 
g68e -65.3205 0.093386 -38.8766 1.156544 -26.444 1.160308 
h69q -62.5469 0.108003 -34.1858 1.015799 -28.3611 1.021524 
h69y -71.7393 0.095738 -36.6708 1.139597 -35.0685 1.143611 
h69a -65.6638 0.097901 -31.3036 1.241289 -34.3601 1.245144 
a71l -64.8642 0.089519 -35.7442 0.990664 -29.12 0.9947 
a71t -71.439 0.099204 -37.5238 1.023101 -33.9153 1.027899 
a71g -65.7517 0.096475 -36.0125 0.985569 -29.7393 0.99028 
v77k -62.7329 0.105156 -35.6966 1.182801 -27.0363 1.187466 
v77l -62.94 0.111071 -33.5639 0.995191 -29.3761 1.00137 
v77i -63.7596 0.094357 -34.4918 1.069006 -29.2678 1.073162 
v77a -57.5645 0.105802 -34.6001 1.052605 -22.9644 1.057909 
v82i -66.47 0.099632 -34.4111 1.146153 -32.059 1.150475 
v82a -63.2452 0.094301 -33.806 0.987082 -29.4392 0.991576 
v82l -61.7741 0.090315 -34.1393 1.01639 -27.6348 1.020395 
v82g -62.2093 0.087901 -36.6276 1.204683 -25.5818 1.207886 
n88d -66.4672 0.087265 -37.3541 1.039966 -29.1132 1.043621 
i93l -61.948 0.089661 -35.7891 1.063574 -26.1589 1.067347 
i93a -65.9971 0.089704 -35.7541 1.042918 -30.2431 1.046769 
g94e -57.2807 0.091632 -32.0617 0.987694 -25.2191 0.991935 




Table AB.2: The binding affinities of all the mutants and wild type structures towards 
the transition state analogue corresponding to the MC/CA substrate. The mean energies 
are reported in kcal/mole with the standard error in following column.  
 
Mutants H SE -TS SE GT SE 
i13a -87.1343 0.110586 -36.8217 1.211302 -50.3126 1.21634 
i13l -87.8429 0.10825 -39.3112 1.132012 -48.5317 1.137176 
g17e -84.7531 0.099002 -37.9752 1.180029 -46.7778 1.184175 
v32i -88.5417 0.101283 -38.1173 1.145245 -50.4245 1.149715 
m36v -90.0149 0.107252 -41.1197 1.147773 -48.8953 1.152773 
m36i -85.7079 0.100256 -38.4605 1.143583 -47.2475 1.147969 
m36a -83.9506 0.098677 -38.078 1.049357 -45.8725 1.053986 
n37s -88.6927 0.118596 -36.4497 1.126932 -52.2431 1.133155 
n37d -79.1307 0.10182 -39.1252 1.156057 -40.0054 1.160532 
n37q -82.2196 0.116751 -39.2061 1.110314 -43.0135 1.116435 
g40e -75.9423 0.112809 -38.25 1.12774 -37.6923 1.133368 
k43r -88.0244 0.105611 -37.162 1.062024 -50.8624 1.067262 
m46v -97.6834 0.105921 -43.2685 1.1631 -54.4149 1.167913 
m46t -84.2464 0.11061 -38.0921 1.094846 -46.1542 1.100419 
g48e -73.5539 0.102521 -35.8008 1.071379 -37.7531 1.076273 
g48v -91.4041 0.10213 -38.5531 1.155831 -52.8511 1.160334 
l63p -85.9812 0.100585 -37.6951 1.082316 -48.286 1.08698 
l63v -86.4485 0.104139 -40.9508 1.081792 -45.4977 1.086793 
l63k -93.6486 0.10483 -37.5526 1.11499 -56.096 1.119907 
l63g -87.9916 0.104273 -37.4295 1.140728 -50.5621 1.145484 
l63a -87.7329 0.096801 -40.5782 1.15096 -47.1547 1.155024 
190

g68e -77.8527 0.103745 -38.949 1.112852 -38.9037 1.117677 
h69q -86.2313 0.097717 -37.4404 1.032956 -48.7909 1.037568 
h69y -93.1042 0.108702 -39.3333 1.223202 -53.7709 1.228022 
h69a -83.1344 0.101177 -35.0961 1.059667 -48.0383 1.064486 
a71l -82.3045 0.108139 -37.4812 1.140884 -44.8233 1.145998 
a71t -94.6324 0.102572 -38.1378 1.035745 -56.4946 1.040812 
a71g -89.4727 0.100441 -38.0418 1.244777 -51.4309 1.248823 
v77k -98.6776 0.098711 -40.2531 1.147883 -58.4246 1.152119 
v77l -82.0941 0.093702 -37.5572 1.049512 -44.537 1.053687 
v77i -90.1835 0.0947 -37.968 1.014577 -52.2155 1.018987 
v77a -86.278 0.102356 -39.8335 1.100628 -46.4444 1.105377 
v82i -91.7837 0.103785 -43.9451 1.202279 -47.8385 1.20675 
v82a -82.1556 0.102785 -40.9517 1.158702 -41.2039 1.163252 
v82l -85.6853 0.106311 -37.4827 1.182387 -48.2026 1.187157 
v82g -84.9443 0.118185 -36.966 1.179196 -47.9783 1.185104 
n88d -78.8088 0.106642 -35.7657 1.148305 -43.0431 1.153246 
i93l -88.5851 0.099062 -40.0603 1.109916 -48.5248 1.114328 
i93a -87.534 0.107019 -39.8231 1.218833 -47.7109 1.223522 
g94e -77.0317 0.105226 -40.5565 1.072927 -36.4752 1.078075 


























g17e 35 5 -16.5212 5 -46.7778 6 
m36v 30 4 -21.2218 8 -48.8953 8 
n37s 55 8 -22.7608 10 -52.2431 11 
g40e 0 1 -9.2041 1 -37.6923 1 
k43r 50 7 -21.1083 8 -50.8624 9 
m46v 100 11 -27.9847 11 -54.4149 12 
m46t 40 6 -15.8026 4 -46.1542 5 
g48e 3 3 -11.1195 2 -37.7531 1 
l63p 98 10 -19.796 6 -48.286 7 
l63v 62 9 -19.6474 6 -45.4977 4 
n88d 0 1 -13.93 3 -43.0431 3 
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